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Abstract 
Resistance to antibiotics by microbial pathogens continues to be a major global health problem. 
Treatment of bacterial infections is becoming increasingly complex and expensive. 
Tuberculosis (TB), caused by Mycobacterium tuberculosis infection, is affected by antibiotic 
resistance. In South Africa, the Western Province is the worst affected, with an increasing 
incidence of both multi-drug resistant (MDR) and extensively drug resistant (XDR) strains of 
M. tuberculosis. Both resistant forms of TB increase the length of treatment to almost 
24 months and cost by as much as 1400 times that of regular anti-tubercular chemotherapy. A 
potential solution to this problem is the discovery of new drugs, which can be obtained from 
natural sources. Actinomycetes are good sources of these drugs, with over 45% of current 
medicines derived from these bacteria. The actinobacterium Streptomyces polyantibioticus 
SPRT (SPRT) was locally isolated and first described by Le Roes (2006).  It has been shown to 
produce bioactive molecules active against a range of bacteria, including compounds (drugs) 
that have anti-tubercular properties. One of the anti-tubercular molecules was identified as 2,5-
diphenyloxazole (DPO). DPO is currently used as a component of scintillation fluid for its 
luminescent properties and is synthesised chemically in industry. SPRT is the only reported 
biological source of DPO, it is however not yet produced commercially via a biological route. 
The present study was performed to inform future process development of DPO production 
from SPRT.  
 
An investigation into the growth and production of antimicrobial compounds from submerged 
cultures of SPRT in shake flasks, and scale-up of the process into a laboratory stirred tank 
bioreactor (STR) was done in the present study. The work focused on obtaining growth kinetics 
and suitable operating conditions for cultivation. Characterisation of the growth profile of SPRT 
and determination of the kinetic growth parameters was carried out. Additionally, the 
antimicrobial production phases, and factors influencing their production was investigated. It 
was determined that the most reliable method of measuring biomass concentration was by dry 
cell gravimetric measurement of whole shake flasks following vacuum filtration, as it best 
suited the non-homogenous filamentous nature  of SPRT.  
 
The SPRT culture was grown in shake flasks using Hacène’s medium, at 28 °C with agitation 
and had a growth phase of 12-15 hours at a maximum specific growth rate of 0.260 h-1, 
achieving a maximum biomass concentration of 3.30 ± 0.070 g/L. SPRT produced three sets of 
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metabolites, including 2,5-diphenyloxazole (DPO), when ethyl acetate culture extracts were 
tested on the developed TLC and HPLC protocols. Bacterial overlays and bioautographic tests 
showed that the produced molecules displayed antimicrobial activity against Escherichia coli 
(ATCC 25922), Staphylococcus aureus (ATCC 25923) and Mycobacterium aurum A+. The 
production of DPO and the other antimicrobials was facultatively growth associated. The 
maximum DPO concentration achieved was 286 µg/L. 
Foaming was a major challenge for cultivation of SPRT in the STR. A number of strategies for 
the alleviation of foaming were employed. These included the addition of antifoam, a 
mechanical foam breaker and pH control. Upon stable cultivation of SPRT in the STR, a 
comparable maximum specific growth rate and biomass concentration to shake flask cultures 
were achieved (0.266 ± 0.002 h-1 and 3.53 g/L respectively). Antimicrobial production was 
observed in negligible amounts.  
 
Shake flask experiments in which the initial concentration of the glucose in the medium was 
increased two- and four- fold did not result in further biomass production, suggesting a different 
limiting nutrient. The cultures continued to utilise glucose at the same rate after the maximum 
biomass concentration was achieved, but this did not result in an increase in antimicrobial 
production. A change in culture temperature from 28 °C to either 20, 30, 37 or 45°C did not 
substantially affect the overall production of antimicrobials. The level of each bioactive 
metabolite was uniquely affected at each temperature resulting in different ratios occurring.  
 
This study has provided kinetic data pertaining to the growth and antimicrobial production 
patterns of SPRT at lab scale (shake flasks and stirred tank bioreactors). It has also highlighted 
challenges that should be addressed prior to further scale-up of the process. This information 
can be used as a reference point for additional optimisation studies aimed at improving yields 
of DPO and other bioactive molecules. 
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Chapter 1:  Introduction 
1.1 Background and Study Scope 
Antibiotics have revolutionised contemporary medicine allowing fatal diseases to be treated. 
There is, however, a growing concern about antibiotic resistant strains of microbes. An ever 
increasing need for novel antibiotics with unique modes of action exists, as currently used 
antibiotics become more and more ineffective (Okudoh and Wallis 2007).   
 
One area of impact of antibiotic resistance is in tuberculosis. Africa is currently facing the 
worst tuberculosis (TB) epidemic, with the rise in antibiotic resistance of great concern. 
Resistance to TB has resulted due to misuse of antibiotics by both patients and doctors. This 
has led to the emergence of multi-drug resistant strains of Mycobacterium tuberculosis. It is of 
immediate importance in South Africa, among the top five countries in the world, with respect 
to multi-drug resistant TB strains. South Africa is plagued with both high TB incidence rates 
and high rates of co-infection with Human immunodeficiency virus (HIV). New drugs are 
required to combat this and are typically sought from natural sources. 
 
Molecular diversity underpins biological diversity, thus for an increased chance of discovering 
novel antibiotics, bioprospecting for antibiotics requires selective isolation of novel 
microorganisms. There is an increased chance of finding novel taxa when searching in extreme 
and or neglected habitats. A number of screening steps are required to identify bioactive 
molecules of interest and characterise their structural chemistry, mode of action and potency 
(Goodfellow and Fiedler 2010). Candidate molecules and their producing microorganisms can 
then be engineered into a bioprocess. 
 
During routine isolation and screening at the Department of Molecular and Cell Biology at the 
University of Cape Town, a novel strain of Streptomyces was isolated. This bacterium, 
Streptomyces polyantibioticus SPRT (SPRT), was found to produce multiple bioactive 
metabolites with antimicrobial activity against common bacterial pathogens, both gram 
negative and gram positive. Amongst these metabolites, 2,5-diphenyloxazole (DPO) was 
produced, which has anti-tubercular properties (Le Roes 2006). This compound/drug is 
currently only produced by chemical synthesis through a production process involving multiple 
step reaction schemes and harsh reaction conditions (Giddens et al. 2005; Wan et al. 2010; Xu 
Chapter 1                                         Introduction 
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et al. 2013). The preliminary study by Le Roes (2006) thus presented the only known biological 
source of DPO; providing a source of the molecule which is produced relatively simply under 
less harsh conditions and is potentially cheaper.    
 
To facilitate production of DPO or similar compounds, it may be necessary to modify the cell 
genetics and optimise cultivation (fermentation) conditions for higher product yields (Liu et al. 
2013). Growth kinetics and operating conditions for cultivation are considered in the present 
study, with taxonomic studies, bacterial isolation and genetic manipulation lying outside the 
scope. 
 
The present study was conducted to provide detailed information on the growth of SPRT and 
its production of antimicrobial molecules; specifically, to understand the growth patterns of 
SPRT in laboratory scale bioreactors (shake flasks and stirred-tank bioreactors). The study aims 
to inform the future development of a scalable and commercially viable industrial system for 
the production of antimicrobials from SPRT.  
 
1.2 Thesis Structure 
This thesis comprises six chapters. In Chapter 1, an overview of the study is provided, giving 
context towards the objectives and research approach. The literature is reviewed in Chapter 2 
outlining the history and need for antibiotics. A description of actinomycetes follows including 
physiological and phylogenetic information, as well as their ability to produce antibiotics. 
Furthermore what is known of SPRT physiology and antibiotic producing ability is presented. 
Additionally the bioprocess challenges associated with filamentous culture, especially those of 
Streptomycetes, which require consideration are outlined. Analysis of the gaps in the literature 
is used to establish the research objectives and key questions, these conclude the chapter. In 
Chapter 3, the materials and methods used in this study are presented. Further, the development 
of the analytical procedures for SPRT biomass and antimicrobial determination necessary for 
this study are presented in Chapter 4. The results from shake flask and lab scale bioreactor 
experiments detailing growth profiles and associated growth rates and yields in each set-up are 
found in Chapter 5. The effects of altering the initial carbon concentration on SPRT growth is 
investigated. The antimicrobial metabolite production profiles in both shake flask and stirred 
Chapter 1                                         Introduction 
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tank bioreactors are shown, followed by a general discussion concluding the chapter. The 
conclusions and recommendations for further work are presented in Chapter 6. 
Chapter 2                     Literature Review 
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Chapter 2:  Literature Review 
 
2.1 Antibiotics and antibiotic resistance 
Ancient societies as old as 2000 years made use of traditional medicines comprised of plant 
and fungal extracts with antimicrobial properties (Lindblad 2008). Antibiotics began to appear 
in modern clinical medicine in the mid-20th century with the use of penicillins and gramicidin 
(Bush 2004). Today, there is a wide range of antibiotics in use with the major classes including 
cephalosporin, tetracyclins, ansamycins, glycopeptides and quinolones. Across these many 
types of current antibiotics, there are only a few mechanisms of action (Yoneyama and 
Katsumata 2006). These include inhibition of cell wall synthesis, nucleic acid synthesis, and 
protein synthesis (Piddock 1998). Due to antibiotic resistance, new drugs are required to make 
up for the ever increasing number of ineffective drugs to which resistance is shown. Pathogenic 
microorganisms evolve to become antibiotic resistant via natural mutations, many of which are 
plasmid borne and easily transmitted. Overuse of broad spectrum antibiotics and ignorance has 
led to negligent use of prescribed antibiotics by society, exacerbating the problem (Levy 1998; 
Powers 2004; Yoneyama and Katsumata 2006; D’Costa et al. 2011; Nathan and Cars 2014). 
  
Antibiotic resistance is a contemporary issue. Key organisations such as the Centres for Disease 
Control (CDC), World Health Organisation (WHO), World Economic Fund (WEF) and World 
Health Assembly (WHA) place key focus on antibiotic resistance (Nathan and Cars 2014). 
Without urgent coordinated action, treatable common infections and minor injuries will once 
again become lethal. Resistance to first and second line drugs once effective against Neisseria 
gonorrhoeae (gonorrhoea), Escherichia coli (urinary tract, and intestinal infections) and 
Staphylococcus aureus (skin infections, common hospital pathogen) has become widespread. 
This is expected to lead to them becoming as notoriously problematic and lethal as antibiotic 
resistant strains of Plasmodium falciparum (Malaria) and Mycobacterium tuberculosis 
(Tuberculosis). 
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2.2 Tuberculosis and available antibiotics 
Tuberculosis (TB), a droplet infection affecting the lungs, brain, intestines, kidneys and spine 
is caused by the bacillus M. tuberculosis. It is a prime example of a disease affected by 
antibiotic resistance. TB, the first infectious disease to be declared as a global emergency by 
the WHO, has high morbidity and mortality rates in developing countries (Zaman 2010). The 
TB threat is particularly relevant to Sub-Saharan Africa owing to the concomitant prevalence 
of (HIV-AIDS). In South Africa, the Western Province is the worst affected, with an increasing 
incidence of both multi-drug resistant (MDR) and extensively drug resistant (XDR) strains of 
M. tuberculosis (Gandhi et al. 2006; Andrews et al. 2007). Both resistant forms of TB increase 
the length of antitubercular chemotherapy to almost 24 months and cost by as much as 1400 
times that of regular treatment (Bateman 2006).  
 
Despite advances in TB diagnosis over the years, the current methods of treatment are little 
changed, with the newest approved TB drug, rifampicin, having been discovered almost fifty 
years ago. As a result, survival rates of most patients with MDR- or XDR-TB are declining. 
HIV co-infection (SA 520 cases per 100 000 people) exacerbates the TB problem, by 
interfering with initial diagnosis and the immune-compromised state complicating the TB 
infection (Andrews et al. 2007; WHO, 2015). The solution to combat these problems is novel 
TB drugs, with unique structures and unusual antimicrobial mechanisms of action to ensure 
long-lasting and effective antibiotics, since new antibiotics of the same classes as those already 
in use will likely be susceptible to cross resistance (File 1999). Ideally, the drugs should be 
capable of killing MDR- and XDR-TB, in a period shorter than the current six months required 
for treatment (van Wezel et al. 2006). A reduced number of pills required, reduced dosage 
frequency and no undesirable side effects would also help simplify treatments. Compatibility 
with HIV drugs and ability to kill latent TB (Goldfeld and Ellner 2007; King et al. 2010) are 
desirable for HIV co-infection and to reduce the prevalence and number of deaths caused by 
TB, in line with the mission and targets of the Global Plan to stop TB 
(http://www.stoptb.org/global/plan/) – an initiative of the WHO.  
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2.3 Drug discovery  
Products found naturally in the environment have provided a rich source of multifarious 
chemical structures. New antibiotics can be derived from natural products. Natural products 
from microorganisms, particularly bacterial secondary metabolites, have shown potential with 
actinobacteria typically being a good source. It has been estimated that fewer than 3% of all 
antibiotics have been discovered; therefore, there is still a high chance of being able to isolate 
new antibiotic molecules from bacteria and, particularly, actinobacteria.  Isolation of molecules 
with antimicrobial properties has historically come from terrestrial sources. These sources are 
widely studied mostly due to easy access. Despite past success, the larger pharmaceutical 
companies no longer prioritise natural product discovery and finding novel antibiotics is 
becoming less common, however the potential to find many novel antibiotics remains. It 
therefore falls to other players such as universities and small biotech companies to fill this gap 
(Nathan and Cars 2014). Improved high throughput screening methods with de-replication 
technologies, are being developed and reduce the occurrence of rediscovering known 
molecules and their producing microorganisms (Lam 2006; Goodfellow and Fiedler 2010). 
One must also be careful not to disregard a test isolate of species already isolated too early as 
antibiotic production is strain specific (Kokare 2008).  
 
2.4 Actinomycetes 
In 2009, the order Actinomycetales was one of five orders belonging to the class 
Actinobacteria, the others were Acidimicrobiales, Bifidobacteriales, Coriobacteriales and 
Rubrobacterales, (Zhi et al. 2009) and this has since been amended due to the increasing 
number of novel species being discovered. There are 13 sub-orders within the Actinomycetales 
which encompasses 42 families.   
 
Bacteria belonging to the class Actinobacteria are Gram-positive with high (greater than 50%) 
guanine cytosine (G+C) content (Stackebrandt et al. 1997). The word actinomycetes is of 
Greek origin meaning “ray fungus” as they closely resemble fungi due to their filamentous 
nature (Lechevalier and Lechevalier 1981). Many are spore forming aerobes. They have a 
variety of life cycles. Spore-forming strains produce spores which may occur as conidia, 
illustrated in Figure 2.1 (A) and Figure 2.1 (B), or sporangia. Various strain specific spore 
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surface morphologies occur and can be differentiated by the use of an electron microscope as 
seen in Figure 1(B) (Lechevalier, 1989). 
 
 
 
Figure 2.1 (A) Morphological features and typical developmental cycle of actinomycetes. [Adapted from Hempel (2012)]  (B) 
Electron micrograph showing (spiny) spore surface ornamentation and (Spirales) spore chain morphology of an 
actinomycete isolate. [Sourced from Matongo (2011)] 
 
Actinomycetes are typically saprophytic bacteria, residing in all ecological niches in both 
natural and man-made environments. These include locations such as compost, fresh and salt 
water, soils and some extreme environments (Kokare 2008). They sometimes associate with 
Chapter 2                     Literature Review 
 
Page | 8  
   
plants and animals forming mutualistic relationships (Hasegawa et al. 2006). Environmental 
factors such as pH and temperature have a bearing on their role and distribution in their 
surroundings.  
Generally, actinomycetes are mesophiles with optimal growth between 25-30°C. There are 
exceptions with facultative thermophiles, such as Thermoactiomycetes and 
Saccharomonospora, growing at temperatures above 40°C. These can be found in more 
uncommon environments such as the deep sea and in self-heating compost heaps (Kokare 
2008). Actinomycetes play a vital role in the decomposition and recycling of organic matter, 
as they are able to decompose complex and recalcitrant polymers such as lignin, cellulose, 
lignocellulose, chitin, keratin, hemicellulose, fungal cell wall material and pectin (Kokare 
2008). This can be attributed to their broad metabolic capabilities. Whilst actinomycetes are 
generally salt tolerant, this can be used to separate terrestrial strains from marine strains. 
Marine strains have an even higher salt tolerance. Deep sea actinomycetes are obligate in their 
requirement for sea water whereas terrestrial strains are only facultatively marine. Exploiting 
these properties and characteristics, and mimicking natural conditions in the laboratory allows 
actinomycetes to be selectively isolated from the environment (Goodfellow and Williams 1983; 
Kurtböke and Williams 1991). More importantly it is the recreation of the environment 
(Gavrish et al. 2008) from whence they were isolated which leads to higher success rates of 
producing desirable bioactive metabolites such as antibiotics.   
 
2.5 Actinomycetes: a source of antibiotics and other useful compounds. 
Actinomycetes, primarily streptomycete, are involved in antagonistic interactions in their 
environment. Rhizosphere Streptomyces suppress growth of fungal root pathogens and 
Actinoplanes regulate plant diseases (Kokare 2008). The ability of actinomycetes to produce 
bioactive compounds and other secondary metabolites under low nutrient conditions allows 
them to secure their survival in their niche by eradicating competitors (Maplestone et al. 1992). 
The systematic screening of actinomycetes for their antibiotics began with Selman Waksman 
in 1914 (Bush 2004). Today it is known that actinomycetes are one of the best sources of 
antimicrobial compounds, with the vast majority of the current antibiotics produced originating 
from actinomycetes (Marinelli and Marcone 2011). Antibiotics with a vast range of chemical 
structures and mechanisms of action are produced. Table 2.1 lists the major classes of 
Chapter 2                     Literature Review 
 
Page | 9  
   
antibacterial (by chemical structure) on the market along with their cellular targets (Marinelli 
and Marcone 2011). In addition to antibiotics, biosurfactants, enzymes, enzyme regulators, 
plant growth promoting substances and immunomodifiers are produced (Kokare 2008). 
Eukaryotic sources are at this stage not a viable source of bioactive secondary metabolites as 
they have more complex, relatively less understood biosynthetic and associated regulation 
pathways (Lane and Moore 2011) and seldom reach market. 
 
Furthermore it has been reported that the average actinomycete has the genetic potential to 
produce 20 or more secondary metabolites (Donadio et al. 2002; Baltz 2011) with 
streptomycetes having the genetic capacity for 40 distinct secondary metabolites (Yoon and 
Nodwell 2014).  The difficulty is that the majority of these genes are expressed at low levels at 
laboratory scale (Yoon and Nodwell 2014). The use of molecular tools to activate these 
‘cryptic’ genes can be tricky especially when the gene clusters are unknown. Some success has 
been reported from the use of crude methods, (e.g. co-culture, change in conditions – a ‘shock’ 
or addition of chemicals), to elicit a stress response to trigger antimicrobial production and or 
improve fermentation titres (Table 2.2) in conjuncture with recombinant DNA technologies 
(Wang et al. 2012; Bertrand et al. 2014; Bode et al. 2002; Yoon and Nodwell 2014; Zhu et al. 
2014).  
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2.5.1 Streptomyces polyantibioticus SPRT  (SPRT) 
SPRT was named for its antibiotic producing potential. It was isolated from the Umgeni River 
in KwaZulu-Natal and has brown substrate mycelium. Figure 2.2 shows filamentous nature of 
SPRT with Rectiflexibiles-type spore chain morphology. SPRT is non-pathogenic. Rigorous 
polyphasic taxonomic work was performed on SPRT during characterisation (Le Roes-Hill and 
Meyers 2009). Growth occurs at 4 and 30°C and at pH 4.3. It is able to utilise a vast array of 
molecules as sole carbon and nitrogen sources. Carbon utilisable by SPRT includes D(-) 
fructose, D(-) lactose, D(+) cellobiose, D(+) galactose, D(+) glucose, D(+) mannose, D(+) 
melibiose, D(+) xylose, meso-insositol, raffinose, salicin, sodium acetate (0.1%), sodium 
citrate (0.1%) and trehalose, whilst adonitol, D(-) mannitol, D(+) melezitose, inulin, L(+) 
arabinose, L(+) rhamnose, sucrose and xylitol are not. Utilisable nitrogen sources includes DL-
α-amino-n-butyric acid, L-arginine, L-cysteine, L-histidine, L-hydroxyproline, L-
phenylalanine, L-serine, L-threonine, L-valine and  potassium nitrate.  SPRT showed weak 
utilisation of ribose and L-methionine (Le Roes-Hill and Meyers 2009).   
 
 
Figure 2.2 Cryo-scanning electron micrograph of strain SPRT grown on Middlebrook 7H9-glucose agar at 30 °C for 19 days. 
[Adapted from Le Roes (2006)] 
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Limited research on antibiotic production of SPRT has been done as preliminary screening. 
Molecules produced by SPRT showed activity against all bacteria used in the test (Table 2.3), 
with stronger activity against Gram-positives. Activity against both Gram-positive and Gram-
negative pathogens was to be expected because they have overlapping, target profiles. The 
stronger activity against Gram-positives is unusual as Gram-negatives are usually easier to kill 
due to their weaker cell wall structure (Le Roes 2006; Le Roes-Hill and Meyers 2009; Walsh 
and Wencewicz 2014).  
 
Thin layer Chromatography coupled with Bioautography on culture extracts of SPRT initially 
showed five different fractions exhibiting antimycobacterial properties. High Performance 
Liquid Chromatography, Nuclear Magnetic Resonance and Mass Spectral analysis confirmed 
one of those fractions to contain 2,5-diphenyloxazole (DPO). DPO (Figure 2.3) has uses in 
liquid scintillation spectrometry and is in preliminary development as an anti-TB drug. This is 
the only documented biological source of DPO; hence, it is of great interest. Two of the other 
fractions were designated EAM115B and EAM115P; these were deduced by Le Roes (2006) 
to be different configurations of the same antimicrobial compound.  EAM115B/P was a pH 
indicator antibiotic: it is blue-purple in the presence of 6M HCl and luminous pink in the 
presence of 10M NaOH. Subsequent SPRT culture extracts only showed three antimicrobial 
fractions, leading to the conclusion that SPRT had either stopped or lost the ability to produce 
EAM115B/P (Le Roes 2006).  
 
Table 2.3 The range of antibiotic activity exhibited by SPRT [Adapted from Le Roes (2006)] 
 
*clinical isolates,  GRAS = generally regarded as safe 
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Figure 2.3 Structure of 2,5-diphenyloxazole produced by SPRT as determined by X-ray crystallography [sourced from 
Le Roes (2006)] 
 
2.6 Bioprocess Considerations 
The production of antibiotics from actinomycete bacteria needs to be scaled-up and assessed 
for potential commercial scale production. To enable the efficient design and optimisation of 
industrial microbial cultivations, for controlled operation, knowledge of basic kinetic 
parameters such as the growth and product formation rates, yields of growth and product 
formation and an understanding of microbial physiology is necessary. This enables researchers 
to develop, optimise, model and scale (Appendix A) a bioprocess (Koutinas et al. 2003; 
Rahulan et al. 2012).  
 
Living organisms have highly complex metabolic pathways which adapt to their environment. 
Their metabolic performance in a bioreactor depends on complex interactions of the various 
operating conditions. Whilst continuous steady state processes give the highest productivity, 
the complexity of microbial systems and process challenges, such as sterility, has resulted in 
most industrial processes being run in a batch or semi-batch manner. Systems in which 
secondary metabolites are harvested are particularly poorly suited to continuous culture as the 
low specific growth rate needed for product formation results in long (infinite) residence times, 
and thereby a two-stage continuous process. Secondary metabolites are regulated in a complex 
manner and typically require a change in conditions, usually those of a stressful nature, to be 
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produced (e.g. change in phase from growth to stationary), making batch and fed-batch 
conditions more suitable for their production (Glazer and Nikaido 2007). The resultant 
environment of the microbial culture is dependent on both biological and operational 
parameters which are process specific.  
 
Scaling of biological systems from laboratory scale to a viable commercial production system 
is a lot more challenging than chemical processes, as microbes are more sensitive to changes 
in environmental variables such as raw materials, pH, temperature, oxygen, ionic strength, 
mass transfer, circulation time, shear stress and hydrodynamic forces (Vanags et al. 1995; Silva 
et al. 2001; Koutinas et al. 2003; Rahulan et al. 2011).  These affect biomass production, 
morphology and product formation, both in terms ofquality and quantity (Hsu and Wu 2002). 
The impact of a single parameter is often scale dependent (Rahulan et al. 2012).  
 
In order to overcome the many issues surrounding optimisation and scale-up, it is imperative 
to identify the critical factor(s) affecting the bioprocess, both in terms of growth and product 
formation. Process conditions for the industrial biological production of antibiotics are mostly 
determined empirically and they mostly constitute proprietary knowledge (Glazer and Nikaido 
2007). This makes development of novel systems challenging. Due to the very process specific 
interactions and uniqueness of various actinomycetes, there is no universally applicable 
strategy or set of process conditions for a successful scale-up (Junker et al. 2004; Xia et al. 
2015).  
 
Some of the major complications associated with cultivation of filamentous organisms, such 
as fungi and actinomycetes, include the viscous nature of the culture, unknown kinetics, and 
heat and mass transfer requirements. These factors often hinder optimisation and scale-up of 
industrial bioprocesses (Koutinas et al. 2003; Rahulan et al. 2012). Morphology and foaming, 
which are common challenges experienced in early stage development, of actinomycete culture 
are reviewed below.  
 
2.6.1  Process challenges of actinomycete culture: Morphology  
Actinomycetes present a range of possible morphologies in submerged culture, ranging from 
predominantly pelleted to predominantly mycelial (filamentous/dispersed) forms. Mycelial 
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cultures are characterised by hyphal geometry (length, diameter and branching frequency), 
whilst pellets and clumps are characterised by their geometry as well as their density (Olsvik 
and Kristiansen 1994), and often classified microscopically and macroscopically, respectively 
(Nielsen 1996). Whitaker (1992) presented an extensive list of the actinomycetes and the 
growth forms they present in shake flasks and stirred vessels. Some strains exclusively 
exhibited one morphological form over the other, whereas others could exhibit both, dependent 
on the prevailing conditions. The predominant morphology during cultivation is dependent on 
several factors, both biological and operational alike, such as the strain, inoculum concentration 
and quality, and agitation (van Wezel et al. 2006; Posch et al. 2013). A summary of these 
interactions is presented in Figure 2.4. Junker et al. (2004) listed the general effects of agitation, 
inoculum, media composition, media additives and fermentation parameters on morphology 
type. These are by no means universal due to multiple interacting factors often resulting in 
counter intuitive effects. For example, increasing agitation has the positive effect of increasing 
critical dissolved oxygen in mycelial cultures of Streptomyces niveus by opening the mycelial 
network (Wang and Fewkes 1977), but the increased turbulence causes increased shear, which 
can be detrimental to growth.  
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Figure 2.4 Summary of the numerous interconnecting factors that interact to determine pellet formation of filamentous 
organisms. [Adapted from (Bailey and Ollis 1986)]. 
Each growth form (pelleted vs dispersed) has unique rheology and kinetics (Mitard and Riba 
1988). These will in turn have a great influence on reactor performance (Olsvik and Kristiansen 
1994). Predominantly pelleted broths consist of discrete compound masses of hyphae, which 
typically display Newtonian behaviour (Heydarian et al. 2002; Kelly et al. 2006). Whilst this 
favours well mixed cultures, mass transfer to the centre of each pellet becomes limited, 
particularly as the pellets increase in size; this results in slower cultivation (Heydarian et al. 
2002; Junker et al. 2004; Grimm et al. 2005). However, there are reports of cultures with 
elliptical ‘doughnut’ shaped pellets, which experience better mass transfer (Hamanaka et al. 
2001).  Growth of pellets are dependent on initial pellet size and may be described by the cube 
root law (Nielsen 1996): 
 
m1/3 = kpt + m01/3 ………………………………………………………. (Equation 1)  
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where m is the pellet mass and m0 is the pellet mass at time t = 0. The parameter kp can be 
specified as a function of the thickness and density of the pellet and the specific growth rate of 
the cells within the pellet (Nielsen 1996; Tough and Prosser 1996).  
 
Cultures which are predominantly suspensions of filamentous mycelia are typically non-
Newtonian and become more viscous than predominantly pelleted cultures, resulting in poor 
mixing and mass transfer (Wang and Fewkes 1977; Gbewonyo and Wang 1983; Liu and Yu 
1993; Posch et al. 2013). The higher apparent viscosities in the mycelial cultures require higher 
energy inputs to maintain mixing and aeration (Liu and Yu 1993). Growth rates are governed 
by rate of tip extension and branching frequency of hyphal elements (Aynsley et al. 1990; 
Viniegra-González et al. 1993; Indermitte et al. 1994). With respect to process design and 
control, it is important to note that the morphologies and rheologies of actinomycetes change 
with time during cultivation, with past studies reporting all combinations of morphology-
rheologies (Charles 1978; Warren et al. 1995; Heydarian et al. 2000; Heydarian et al. 2002). 
Thus, due to complex morphologies, the most accurate growth models need to be process 
specific. 
 
Assuming medium composition and the producing organism remain constant for a process, the 
three major classes of controllable variables to influence culture morphology include inoculum 
type and concentration, addition of polymer additives to the medium and shear forces in the 
fermenter (Paul et al. 1999; Junker et al. 2004). A dispersed inoculum is favourable for 
industrial seed cultures to ensure providing maximum number of growth nuclei (van Wezel et 
al. 2006), homogeneity, and preventing issues related to clogging of peristaltic tubing and 
uniform pipetting (Junker et al. 2004). Strategies to break up clumped biomass in seed cultures 
include the use of a blender, baffled flasks or inclusion of glass beads. These, however, are 
potentially problematic in that purity of culture might be compromised by the use of blender 
or mixer, baffled flasks could cause foaming (outlined further in Section 2.6.2) and the 
effectiveness of glass beads is limited by shaking rate (high shake rate will cause beads to 
damage or break the shake flask and or the cells). The use of a spore inoculum is effective in 
providing homogenous seed cultures, but additional time during process start-up is required to 
allow for sporulation to occur (Junker et al. 2004). 
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Of the cultivation parameters which can be adjusted to influence the morphology of 
actinomycetes in submerged culture, agitation requires great attention. Primarily agitation 
during microbial cultivation is to provide improved mixing, heat, and mass transfer (Smith et 
al. 1990). The lower limit on agitation rates are set by mass transfer considerations (mainly of 
dissolved oxygen and carbon dioxide).  However, the induced turbulence may alter microbial 
activity (Chisti 2002; Groslambert et al. 2002) and the upper limits are often dictated by shear-
sensitivity of biomass (Blanch and Bhavaraju 1976).  
 
 
2.6.2 Process challenges of actinomycete culture: Foaming in stirred tank bioreactors 
Gas dispersion within the medium is required to provide gaseous exchange for microbes. 
Sparging at the bottom of the bioreactor provides air to the medium. The air bubbles travel 
through the medium and erupt from the liquid surface and exit through the outlet at the top of 
the vessel. Gas holdup is the volume of gas (air) held within the medium; whilst it is held up 
in the medium, gaseous exchange takes place through the gas-liquid and liquid-microbe 
interfaces. Foam is the distribution of a gas in a continuous liquid phase, with linking lamella, 
where the gas phase is the dominant phase. Foam is formed when the gas bubbles provided by 
sparging do not disengage from the media and are stabilised. Foam has a larger gas-to-liquid 
volume ratio (usually greater than 3) than regular gas holdup and the gas bubbles are not as 
spherical (Prins and van’t Riet 1987; Riet and Tramper 1991; Vardar-Sukan 1991). Foaming 
is dynamic, especially in bioprocesses and can be classified as being stable, unstable or 
metastable, dependent on the bioprocess and the prevailing conditions (Junker 2007).  
 
Foaming is a process challenge commonly occurring in stirred tank bioreactors. There are many 
contributing factors that lead to foam formation and govern its severity in bioreactors.  These 
include gas bubbles (aeration and off gas evolution), surface active compounds, operating 
conditions and reactor vessel geometry (Delvigne and Lecomte 2010). Table 2.4 shows a 
summary of the impact that operating conditions have on foam formation. The major 
contributing surface active compounds are proteins, as medium components, microbial 
metabolites and expelled contents of lysed cells. Other surface active compounds include 
lipopolysaccharides (LPS), lipopeptides, pigments, salts, carbohydrates and alcohols, which 
are either components of the growth medium or metabolites of the microorganism. In addition 
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to the metabolic activity of microbes, their physical presence (and that of other solids) affects 
foam formation and stability (Junker 2007; Delvigne and Lecomte 2010).  
 
Foam tolerance is process dependent. Typically excessive foaming is unacceptable; however, 
even mild transient foams can cause undesirable effects. During the microbial cultivation 
foaming can remove biomass from the liquid culture and associated bulk environment, 
resulting in lower productivity. Cells may also be trapped in the foam and experience nutrient 
limitation, forcing a change in microbial metabolism and cell death. Cells caught in foam can 
contribute to foam stability by excreting proteins or LPS and in extreme cases, lysing, further 
exacerbating the problem. Foaming may promote wall growth and biofilm formation, leading 
to culture non-homogeneity, which interferes with monitoring equipment and results in non-
representative sampling (Vardar-Sukan 1991; Junker 2007; Delvigne and Lecomte 2010) and 
incorrect process adjustment based on the erroneous readings.  
 
Foaming can also lead to challenges with liquid containment. Foam increases gas hold up, 
resulting in elevated liquid levels and upsetting bioreactor configurations based on working 
volume (Vardar-Sukan 1991), such as mixing patterns and medium addition in fed batch and 
continuous systems. Breach of liquid containment can be far reaching if medium components 
are corrosive and/or hazardous (Junker 2007).  
 
Whilst the increased back pressure (owing to obstructed filters) and gas holdup caused by 
foaming actually favours mass transfer, cultivations in which foaming occurs, can often 
experience mass transfer problems. Addition of chemical defoamers can induce gas bubble 
coalescence and form thin layers around said bubbles adding another barrier to transfer (Pelton 
2002). The increased gas retention time can also result in oxygen depleted bubbles and carbon 
dioxide accumulation (Junker 2007). 
 
Besides manual foam observation, various detectors can be used to detect the foam levels and 
its stability. Conductivity or resistivity probes are most commonly used.  However, these are 
often susceptible to fouling. Other detector technologies include capacitance, ultrasonic and 
radio frequency admittance systems. There are various chemical, physical and mechanical 
methods that can be used in foam mitigation. Often a combination of these are used in 
bioprocesses (Junker 2007; Delvigne and Lecomte 2010).  
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‘Antifoam’ is the general term used for  chemical substances used in combating foam; though 
technically ‘antifoams’ are agents that prevent foam formation and are added to media prior to 
cultivation, whereas ‘defoamers’ are agents that break up already formed foam and are dosed 
as required (Delvigne and Lecomte 2010). Antifoams and defoamers are, however, 
fundamentally the same type of chemical (Pelton 2002). Commercial antifoams typically 
consist of oils, hydrophobic solid particles, long chain alcohols, fatty acids/esters, polyesters, 
or a combination there of (Delvigne and Lecomte 2010). 
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A good antifoam should suppress foam, be quick acting, cheap, and only be required in 
miniscule amounts to limit interference in the overall bioprocess. However, antifoams do 
negatively affect the bioprocess by reducing mass transfer (additional barrier at gas-liquid 
interface), increasing the mixing power required (lowering gas entrainment), affecting the 
metabolic state of microbes, probe response (e.g. accumulation on membranes) as well as 
downstream processing. For these reasons, non-chemical methods are preferred.  
 
Non-chemical methods, include mechanical foam scrapers or breakers, ultrasound, thermal and 
electrical methods, and adjustment of operating conditions. Ultrasound, thermal and electrical 
treatments are generally not used, primarily due to their adverse effects on the microbes. Aside 
from the mechanical breaker, stirring as foam disruption (SAFD) techniques have been 
developed in which the bioreactor’s hydrodynamics are changed to limit foam formation. 
SAFD techniques work by increasing the liquid velocity at the liquid surface by changing 
impeller geometries and increasing agitation rate, such that foam is disrupted through shear 
stress and wave action (Delvigne and Lecomte 2010). Other operating conditions that can be 
changed include increasing the back pressure, decreasing agitation or decreasing aeration, or 
both, during the process (i.e. minimising the effects shown in Table 2.4). However, these 
adjustments can limit productivity of the organism or bioprocess (Vardar-Sukan 1991; Junker 
2007). 
 
2.7 Research Objective and Key Questions 
The aim of this study was to build on work of Le Roes (2006) and investigate the growth of 
SPRT and its production of DPO and other bioactive molecules in submerged shake flask 
cultivations, followed by scaling-up the process into a laboratory stirred tank bioreactor (STR). 
This was investigated by addressing the following objectives: 
 
a. Develop experimental procedure(s) for characterisation and analysis of biomass 
and antimicrobial production profiles by SPRT. 
b. Determine the growth profile and growth rate of SPRT under standard conditions 
and time of onset of antimicrobial production. 
c. Investigate change in growth and antimicrobial production of SPRT in response to 
modified glucose in the medium and a variation in temperature.  
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The key questions posed in conjunction with the objectives were: 
I. What are the kinetic growth parameters (including time frame, growth phases, rates 
and yields) of SPRT grown in Hacène’s Medium in shake flasks (SF)?   
II. How does SPRT growth compare between the SF and STR? How does this compare 
to the end point data presented by Le Roes (2006)? 
III. What is the relationship between biomass and antimicrobial production phases? 
 
2.8 Research Approach 
In order to achieve the above objectives and answer the key questions, methodology for 
reproducible measurements of filamentous biomass concentration and of DPO concentration 
were developed prior to carrying out standardised growth studies. Shake flask experiments 
grown under the same conditions as Le Roes (2006) were performed with additional 
measurements to establish growth and production profiles. These experiments were used to 
inform scale-up into the stirred tank bioreactor.  
 
In order to investigate antimicrobial production, empirical experiments were carried out, testing 
both association with growth phase and response to stress. No genomic or metabolic flux 
analysis was carried out due to the absence of information of SPRT metabolic pathways in the 
literature. DPO production by SPRT was a key marker for antimicrobial experiments; this was 
based on it being the predominant identifiable bioactive molecule and its potential use as an 
anti-tuberculosis drug. 
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Chapter 3.  Materials and Methods 
3.1    Materials 
3.1.1 Microorganisms 
Bacterial strains used in this study were obtained from Dr Paul Meyers of the Department of 
Molecular and Cell Biology at the University of Cape Town. Streptomyces polyantibioticus  
SPRT (DSM 44925T, NRRL B-24448T) is a pigment producing, spore forming actinomycete 
which produces branching, vegetative mycelia (Le Roes-Hill and Meyers 2009) and was the 
focal strain of the present study. Other bacterial strains used in the present study included 
Mycobacterium aurum A+, Escherichia coli (ATCC 25922) and Staphylococcus aureus 
(ATCC 25923).  
 
For long time storage, stock cultures were made from liquid cultures (1200 µl culture, 300 µl 
80% glycerol) and frozen at -60 °C. Each bacterial strain was maintained as a pure culture, 
using standard agar streak plates. Gram stains and light microscopy [BX40, Olympus Optical 
Company Ltd, Japan] (Burke 1922; Cowan and Steel 1965) were utilised to check their purity.  
 
3.1.2 Culture media 
Standard culture media for bacterial cultivation was used in this study. Luria-Bertani (LB; 10 
g/L tryptone, 5 g/L yeast extract and 5 g/L NaCl), double strength yeast-tryptone broth (2XYT; 
16 g/L tryptone, 10 g/L yeast extract, 5 g/L NaCl) and yeast extract-malt extract agar (ISP 2 or 
YEME; 4.0 g/L glucose, 10.0 g/L malt extract, 4.0 g/L yeast extract, pH 7.3) (Shirling and 
Gottlieb 1966) were used. Agar plates of Difco Middlebrook 7H9 media (7H9), prepared 
according to the manufacturer's specifications (4.7 g/L powder) and supplemented with 
separately autoclaved glucose at 1.8 g/L (i.e. 10 mM) (albumin and catalase omitted), were 
used as a sporulation medium for SPRT. SPRT spores were suspended in Tryptone Soy Broth 
(TSB; Merck, Modderfontein, RSA). Hacène’s medium (HM; 5.0 g/L glucose, 4.0 g/L yeast 
extract powder, 10.0 g/L malt extract and 1.0 g/L sodium chloride, pH 7.4) (Hacène and 
Lefebvre, 1995) was used as production medium for SPRT. Solid plates of the aforementioned 
media were made by adding 15 g/L of agar.  All media and glassware were autoclaved at 121 
°C for 20 minutes prior to use.  
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3.2   Cultivation methods 
3.2.1   Pre-culture preparation  
SPRT was maintained on YEME, M. aurum on 2XYT and E. coli and S. aureus on LB (media 
described in Section 3.1.2). The actinomycetes and bacteria were incubated at 28 °C and 35 °C, 
respectively.  
 
The SPRT inoculum was typically prepared by aseptically removing spores from an agar plate, 
and re-suspending in 5 mL diluted TSB (1 in 5); the TSB helps counteract hydrophobicity of 
the spores by breaking surface tension. The spore suspension was used to inoculate 50 mL HM 
broth in a 500 mL Erlenmeyer flasks, closed with a cotton bung to facilitate mass transfer of 
gas. The flasks were incubated at 28 °C on an orbital shaker at 170 rpm.  
 
3.2.2  Shake flasks 
Bacterial cultures were grown in Erlenmeyer flasks containing culture medium, to a volume 
equivalent to 10 % of the flask volume. A 10 % (v/v) inoculum was used and flasks were 
incubated at 28 °C and 170 rpm. The entire contents of a single flask was sacrificed per time 
point sample. Temperature and pH were monitored in discrete samples using external probes.  
 
3.2.3  Batch stirred tank bioreactor system 
Batch experiments were performed in a 7-L New Brunswick reactor, connected to a New 
Brunswick BioFlo 110 controller (New Brunswick Scientific, USA).  In the reactor system, 
utilising BioCommand software (New Brunswick Scientific, USA) pH, temperature, dissolved 
oxygen and agitation were measured and controlled by means of internal probes (pH: 405-
DPAS-SC-K8S120; dissolved oxygen: InPro 6100/220/S/N Mettler Toledo, Ohio, USA) and 
feedback loops. The culture temperature was maintained by means of a fitted heating jacket 
and an internal cooling coil, through which ethylene glycol (4°C) was pumped. The pH was 
controlled by means of automated titration of 5M KOH and 5M HCl. The culture was aerated 
by sparging compressed air into the reactor after filter sterilisation, using a 0.2 µm Millipore 
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Millex® membrane filter (Merck, Modderfontein, RSA). The exhaust gas outlet was fitted with 
a condenser and two depth filters in series (one column filled with glass beads, followed by 
another column filled with glass wool). Culture homogeneity and mass transfer was ensured 
by agitation via a regulated magnetic drive, equipped with a single six-blade Rushton impeller, 
positioned one third (of culture volume) up from the bottom of the vessel, and four vertical 
baffles lining the inner reactor wall. To contain foaming, a mechanical foam breaker was fitted 
just above the surface of the liquid, and Antifoam 204, (Sigma Aldrich, Missouri, USA) was 
added drop-wise to the medium, as needed.   
 
The inoculum train was as follows:  a 5 mL, diluted TSB spore suspension, prepared as 
described in section 3.2.1 above, was used to inoculate a 500 mL Erlenmeyer flask containing 
50 mL HM. This pre-inoculum culture was grown at 28 °C and 170 rpm for 48 hours. Ten 
millilitres of the pre-inoculum culture was used to inoculate three 1L Erlenmeyer flasks, each 
containing 100 mL HM. These flasks were incubated for 30 – 36 hours at 28°C and 170 rpm. 
The three cultures, combined, were used as the inoculum for the bioreactor experiments. The 
schematic in Figure 3.1 shows an overview of the protocol. The culture system parameters 
outlined in Table 3.1 were used unless otherwise stated.  
 
 
Figure 3.1 The inoculum train used in the bioreactor studies 
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Table 3.1 System parameters for bioreactor experiments  
Parameter Setting 
Organism Streptomyces polyantibioticus 
Medium Hacène’s (HM)  
Culture volume  3 L  (7 L vessel) 
Agitation 250 - 800 rpm (adjusted to maintain DO >40%)  
Aeration  0.75 vvm 
Temperature 28 °C 
pH  7.4 
 ‘rpm’ = revolutions per minute. ‘DO’ = dissolved oxygen, “vvm” = volumeair/volumeculture liquid 
3.3    Extraction of bioactive compounds    
Bioactive compounds were solvent extracted at room temperature from the SPRT culture (shake 
flask /bioreactor) using a method adapted from Taddei et al. (2006). Whole culture samples 
(including cells and liquid medium) were extracted with an equivalent volume of ethyl acetate. 
The mixtures were vigorously hand-shaken for 5 minutes before being transferred to an orbital 
shaker where they were shaken at 90 rpm for 20 hours. Large culture-solvent volumes (>200 
mL) were mixed using a magnetic stirrer. The mixtures were transferred into separating flasks 
and left to stand for a few minutes to allow for separation of aqueous and organic solvent layers. 
The organic layer was removed and retained, while the aqueous layer, containing cells, was 
discarded. Cultures were extracted twice (sequentially) and organic layers pooled. Organic 
layers were concentrated using a rotary evaporator. 
 
3.4    Analytical procedures 
3.4.1  Determination of biomass concentration  
The cell dry weight (CDW) was determined gravimetrically. Culture samples were vacuum-
filtered through 0.45 µm pre-weighed filter paper. The culture filtrate was collected and kept 
for subsequent glucose and pH analysis. The filter cake was dried to constant weight in an oven 
at 75 °C for 48 hours before being cooled in a desiccator. Gravimetric analyses were performed 
in triplicate. 
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3.4.2  Carbon utilisation and formation of organic acids determined by HPLC 
Glucose and glycerol were measured using HPLC, (Finnigan Surveyor Plus, Thermo Scientific, 
Kempton Park, RSA) equipped with a Refractive Index (RI) detector (Finnigan Surveyor RI 
Plus, Thermo Scientific, Kempton Park, RSA), using a Biorad Aminex® HPX-87H organic 
acid column (7.8 mm x 300 mm, Biorad, Cape Town, RSA). Isocratic analyses was performed 
using 0.01M H2SO4, as the mobile phase, and an external column oven set to 40 °C. Samples 
were diluted 20 times in mobile phase before analysis, and the injection volume used was 10 
µl. The flow rate used was 0.5 mL/min. Concentrations of glucose and glycerol in the samples 
were determined by comparing retention times and peak areas to that of a calibration curve 
(Appendix B) constructed from analyses of standard compounds.   
3.4.3 Antimicrobial activity  
3.4.3.1  Bacterial overlays for determination of antimicrobial activity 
Standard bacterial overlays were used as confirmatory tests for known antibiotic activity. SPRT 
was stab inoculated on agar plates of HM and 7H9, allowed to grow for 10 days at 30 °C, 
followed by overlaying with 6 mL sloppy– agar containing an actively growing culture of the 
test bacteria (E. coli, S. aureus and M. aurum) and further incubated for 24 hours (Sambrook 
et al. 1989). Zones of clearance around SPRT were sought. Similarly, plate overlays with stab 
inoculations was replaced by filter paper discs (6 mm in diameter) soaked in crude antibiotic 
extract. The presence of clear zones were a positive indication that SPRT produced bioactive 
molecule(s) with inhibitory activity against the test bacterium, with the zone size being 
indicative of inhibitory strength.   
 
For anti-tubercular activity, the test bacterium used was M. aurum. It is a faster growing, non-
pathogenic mycobacterium with a similar susceptibility profile to that of M. tuberculosis 
(Chung et al. 1995). To investigate a range in activity, E. coli and S. aureus were used as Gram-
negative and Gram-positive controls, respectively.  
 
3.4.3.2 Separation of active compounds using TLC and bio-autography  
Thin Layer Chromatography (TLC) was performed as a quick, qualitative test for the presence 
of active compounds in the culture extracts. The crude “antibiotic” extract was spotted on silica 
TLC plates. Two sets of mobile phases were used to develop the plates including: a) ethyl 
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acetate and acetic acid (90:10 (v/v)) and b) ethyl acetate, hexane and acetic acid (90:9:1 (v/v)). 
The developed plates were visualised under UV light (254nm) and retention factor (Rf) 
compared to a standard, where Rf   is the distance travelled by compound relative to the solvent 
front.   
 
The culture extracts were also subjected to spot - test bioautography according to Betina (1973).  
Volumes of 5, 10, 20 and 25 µl of the extract were spotted on silica TLC plates. An actively 
growing culture of the test bacterium, diluted to an OD600 reading of 0.5, was evenly applied 
onto the prepared TLC plate using sterile non-absorbent cotton discs.  The TLC plates were 
incubated in a humidified container for 24 hours;  E. coli and S. aureus tests incubated at 30 °C 
and M. aurum incubated at 35 °C, temperature selected for optimal growth of each strain.    
Following incubation, a 0.25% solution of thiazolyl blue tetrazolium bromide (MTT) in 
phosphate buffer (MTT Sigma, M2128 ; 1.78 g/L Na2HPO4 , 8.50 g/L NaCl, pH 7.3) was 
evenly applied to the plates, returned to the container and further incubated for  3 hours (12 
hours in the case of M. aurum). The colour change from yellow to violet, attributed to the 
reduction of MTT in the presence of actively respiring cells, was sought. Zones of no activity 
were attributed to the presence of antimicrobials. Bioautographic tests with solvent and 
commercial DPO served as negative and positive controls respectively.  
 
3.4.3.3 Identification and quantification of active compounds using HPLC 
The extracts of the SPRT culture were analysed using HPLC, with UV detection at 303 nm 
(Finnigan Surveyor Plus, Thermo Scientific). Compounds were separated using a Phenomenex 
Luna® C18 (2) 5 μ column (250 mm x 4.6 mm), and a dual mobile phase system, with a linear 
gradient method, as shown in Table 3.2. Mobile phase A consisted of  5% (v/v) methanol and 
1% (v/v) acetic acid, while  mobile phase B comprised of 95%  (v/v) methanol and 1%  (v/v) 
acetic acid.  
 
Table 3.2: HPLC mobile phase gradient profile used in SPRT culture extracts, UV detection at 303nm 
Time (min) 5% MeOH-1%AA 95% MeOH-1%AA Flow rate (mL/min) 
0.0 80.0 20.0 0.8 
1.0 80.0 20.0 0.8 
41.0 0.0 100.0 0.8 
61.0 0.0 100.0 0.8 
61.1 80.0 20.0 0.8 
66.0 80.0 20.0 0.8 
 “MeOH” = Methanol,   “AA” = Acetic acid  
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3.4.4 Data analysis 
Basic statistical analysis (mean, standard deviation and confidence intervals) were used in 
reporting data. T- and F-tests were used to show significant differences when comparing data 
sets. All analyses were performed in Microsoft Excel (2013).  
3.5 Experimental plan 
The objectives of this study were to provide biokinetic data for the growth of SPRT and its 
production of DPO and other bioactive metabolites in liquid cell culture in shake flasks and 
laboratory stirred tank bioreactors. This was addressed by three sets of experiments. 
 
 In the first set of experiments, the methodology for reproducible measurements of filamentous 
biomass concentration and of DPO concentration was developed. Visual observations of SPRT 
biomass in submerged culture were made by direct examination of the culture and the use of 
light microscopy. This informed the choice of parameter by which biomass concentration was 
measured. Optimisation of biomass measurement protocol was done by testing the effects of 
the sampling method, sample volume and sample preparation. The mobile phase composition 
and gradient profile for TLC and HPLC methods was investigated for the analysis of DPO and 
other bioactive molecules.  
 
Having developed the experimental procedures necessary for characterisation and analysis of 
biomass and antimicrobial production by SPRT, standardised growth studies in shake flasks 
were performed to establish production profiles. The shake flask system was used to inform 
scale-up into the stirred tank bioreactor. Experiments to ensure a stable stirred tank bioreactor 
run, with respect to excessive foaming, were performed by adjusting the operational parameters 
(aeration rate, agitation regime, inclusion of mechanical foam breaker, antifoam addition and 
pH control). The previously established shake flask system served as a reference for 
comparison with production profiles obtained from growth studies performed in the stirred tank 
bioreactor.  
 
Further investigation of DPO and bioactive molecules by SPRT was done in a third set of 
experiments by testing both the association with growth phase and response to stress. This 
included cultivations in which the starting glucose concentration in the growth medium and the 
cultivation temperatures were varied.
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 Chapter 4.  Development of Methods  
4.1 Determining biomass concentration of filamentous microorganisms  
4.1.1 Direct methods for measuring biomass.  
Traditional methods to determine the biomass content of microbial cultures include optical 
density (OD), packed mycelial volume (PMV) and gravimetric measurements; cell wet weight 
(CWW) and cell dry weight (CDW) (Posch et al. 2013). The OD of a culture is the degree to 
which it retards light shined through it, determined by the use of a spectrophotometer; the quick 
settling of cells results in inaccurate OD measurements. Furthermore, a homogenous 
suspension is required, where varying particle size due to aggregation and filament formation 
will affect absorbance. PMV is the ratio of biomass to liquid after being subjected to 
centrifugation; complex culture morphology, the impact of morphology on packing and low 
biomass density are limitations to this measurement method. CWW is determined by weighing 
filtered samples before drying; accurately accounting for the moisture content of each sample 
and keeping this consistent can be problematic.  Again, the effect of morphology on packing 
must be recognised.  
 
Streptomyces polyantibioticus SPRT (SPRT) has a non-homogenous filamentous nature (Figure 
4.1), which may influence biomass measurement. Due to the limitations of the methods for 
quantifying biomass mentioned above, dry weight gravimetric measurement following 
centrifugation was used. In separate experiments performed under the same conditions, the cell 
dry weights of SPRT culture samples were analysed using centrifugation in Eppendorf® tubes. 
This data is presented in Figure 4.2. Culture samples of 1 mL were centrifuged at 13 000 rpm 
for 15 min. The supernatant was discarded and cell mass washed with 500 µL distilled water 
and centrifuged at 13 000 rpm for a further 15 min. The supernatant was discarded and samples 
dried for 48 hours at 75 °C before being weighed.  
 
As seen in Figure 4.2, CDW biomass data derived from centrifugation in Eppendorf® tubes 
was highly variable with readings for the same time point differing by up to 1.8 g/L. Very low 
concentrations, such as that of the inoculum, was over  estimated. The water wash step method 
(Figure 4.2A) consistently gave larger variances than data derived without the wash step 
(Figure 4.2B), exhibiting average standard deviations (SD) of 0.51 and 0.43 g/L respectively 
(F-test, p=0.007). 
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Figure 4.1 Images showing typical morphological forms of SPRT in submerged batch culture. A and B were imaged using a 
light microscope, at 1000x magnification. (A) Presence of spores, free hyphal fragments, entangled filaments and 
pellets, (B) Pellets of varying size and density. C and D depict liquid cultures in shake flasks showing 
predominantly (C) pelleted and (D) filamentous forms.  
 
 
Figure 4.2 Dry weight gravimetric analysis of SPR biomass using centrifugation in Eppendorf® tubes (A) with a water wash 
step, (B) without a wash step. The corresponding graphs A’ and B’ show the same information averaged, with 
error bars showing standard deviation of the mean (n=3). 
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4.1.2 Optimisation of Gravimetric analysis: Vacuum Filtration vs Centrifugation  
Different protocols were used to test for measurement accuracy as described by the schematic 
in Figure 4.3. Samples were subjected to either vacuum filtration using filter paper (A-F and 
X) or centrifugation in Eppendorf® tubes (G-W) at 13 000 rpm for 15 min at room temperature 
with varying sample volume, inclusion of intermediary wash step and volume pipetted. The 10 
day old SPR culture was shaken to ensure even distribution of biomass in liquid medium. All 
vacuum filtered samples and centrifuged samples (K-M; S-U) included a water wash step. All 
samples were dried for 48 hours at 75 °C before being weighed to constant mass. The data 
generated from this experiment are presented in Figure 4.4 and Table 4.1. 
 
A wide range of individual biomass concentrations (1.45 – 15.20 g/L), with discrepancies 
between readings taken from different protocols, as well as between technical repeats of the 
same protocol, was obtained with coefficients of variance (COV) ranging between 5.6 and 
97.4% (Table 4.1). On average, samples that followed a filtration protocol (Figure 4.3 A-F and 
X) gave lower biomass readings, 2.45 fold lower than the centrifuged samples (Figure 4.3 G-
W), with 2.59 and 6.36 g/L recorded on average for filtration and centrifugation, respectively.  
Since SPRT biomass has a mixed morphology (Figure 4.1) with mycelia existing as both free 
mycelia and in compact pellets, larger sample volumes give a better overall representation of 
the flask contents. Therefore it was to be expected that across both the filtered and centrifuged 
samples, the smaller the sample volume the larger the discrepancies between repeats and 
resultant deviation. This was not true of all the results obtained in this experiment (Table 4.1) 
with the 2 mL filtered samples (C-D) having a SD of 1.50 g/L which is larger than the SD 
obtained for 1 mL samples (0.92 g/L). Similarly the 1 mL centrifuged samples had SDs that 
were both higher (R-T with SD of 4.16 g/L), and lower (0.70 g/L) than the 2 mL centrifuged 
samples (SDs of 2.16 and 0.36 g/L). 
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Figure 4.4 Biomass readings taken from the same shake flask culture of SPRT using different gravimetric measurement 
methods (see Figure 4.1). Red bars represent vacuum-filtered samples through 0.45 µm nitrocellulose acetate 
filters, blue bars represent samples centrifuged in Eppendorf® tubes at 13 000 rpm for 15 minutes at room 
temperature. The average of technical repeats are shown, with error bars representing the 95% confidence interval 
of the mean.  
 
Table 4.1 Standard Deviations (SD) and coefficients of variance (COV) in CDW measurements taken from the same shake 
flask culture of SPRT (cf Figure 4.3 and Figure 4.4) 
Sample Filtered / 
Centrifuged 
Wash step  
(Y/N) 
Sample size  
(mL) 
CDW 
(g/L) 
SD COV          
(%) 
A,B f Y 5 1.97 0.11 5.6 
C,D f Y 2 3.55 1.50 42.3 
E,F f Y 1 3.40 0.92 27.0 
       
G,H,I c N 2 9.72 2.16 22.2 
J,K,L c Y 2 1.85 0.36 19.2 
M,N c N 1 7.30 0.70 9.6 
O,P,Q c N 1 5.45 2.39 43.9 
R,S,T c Y 1 4.27 4.16 97.4 
U,V,W c N 1 9.60 4.28 44.6 
 
Large standard deviations and potential overestimation of the biomass concentration was likely 
caused by non-representative sampling of the culture. Other causes of errors could be attributed 
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to loss of biomass during various stages of the centrifugation protocols as SPRT did not pellet 
well after centrifugation and biomass was possibly lost when decanting the supernatant. A 
longer centrifugation time might have helped to abate this problem but would have meant a 
lengthy, inconvenient protocol. Further loss of biomass to the sides of containers or of pipette 
tips during transferring of sample could also contribute to the error. Conversely, during vacuum 
filtration, there was no loss of biomass all biomass material was retained in the filter cake, due 
to the use of an absolute filter. 
 
In addition to the causes of error cited above, the difference in biomass concentration  between 
centrifuged samples, in the absence of washing, (G-I) and following a water wash (J-L), 
resulting in mean biomass readings of 9.72 g/L  ± 2.16 and 1.85 g/L  ±  0.36, respectively, 
could be attributed to biofilm formation by SPRT. The water wash step of J-L ensures that 
extracellular polymeric substances (EPSs) were removed and not included in the gravimetric 
reading. 
 
The true biomass concentration of the SPRT shake flask culture was best approximated by 
sample X (1.45 g/L), as its large sample volume and minimisation of intermediary steps 
circumvent most of the problems outlined above. This value was consistent with concentrations 
from other shake flask experiments run under the same conditions (see Section 5, Figure 5.1). 
Vacuum filtered samples A-B (1.97 g/L ± 0.11) and centrifuged samples J-L (1.85 g/L ± 0.36) 
were closest in approaching this true value, with a smaller associated error as compared to the 
centrifugation protocols tested (Figure 4.4.) Protocols A-B and J-L would be sufficient to 
follow trends in biomass concentration, but may prove insufficient where more precise readings 
are needed for further calculations. 
 
Figure 4.5 illustrates the improvement in the quality of gravimetrically-obtained biomass data 
(refer to Appendix C) when the above-mentioned sources of error were minimised by using 
vacuum filtration with a 5 mL sample volume (protocol A-B, Figure 4.3), rather than 
centrifugation of a 1 mL sample (Figure 4.2). The average COV of the data in each experiment 
varied with 17.7, 14.3 and 3.07% obtained for experiments A, B and C, respectively (Figure 
4.5 A-C). The filtration method (Figure 4.1C) resulted in biomass data that gave the expected 
growth curve, whereas the centrifugation methods did not. 
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4.1.3 Gravimetric analysis of SPRT: Sampling bias of pipetting  
Since SPRT cultures are non-homogenous and settling of mycelial biomass occurs, it was 
postulated that pipetting in itself may have a certain inherent bias, in which the ratio of biomass 
to liquid medium in the pipetted sample is not equal to the same ratio in the bulk liquid. To test 
this, a shake flask growth experiment was performed in which each data point was quantified 
by four discrete samples of 5 mL each, taken from a single shake flask culture. These were then 
compared to readings taken from duplicate flasks from which the entire content of the flask 
was sacrificed per data point. CDW analysis was done by filtration with washing. The inoculum 
in all flasks was standardised. The results are displayed in Figure 4.6.  
 
Figure 4.6 Comparison of SPRT growth curve : Blue diamonds represent discrete 5 mL samples, red circles represent full 
contents of the shake flask sacrificed (25 mL) per data point.  
 
The growth curve obtained from the discrete 5 mL samples exhibited a similar overall trend as 
the sacrificed flasks in which 25 mL culture was filtered as the sample. However, the pipetted 
samples consistently exhibited over-estimated CDWs (T-test, p ≤ 0.01). The pipetted samples 
also displayed a trend, where at each time point, each pipetted sample would yield a CDW 
which was progressively lower than the previous one in terms of order of sampling. This 
suggested that the suction action of the pipettes did demonstrate some bias in which biomass 
was collected in preference to medium and hence, an elevated CDW was achieved. To obtain 
representative CDW readings, the entire contents of a single flask should be used to represent 
a data point, rather than discrete samples taken by pipetting. 
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4.1.4 Gravimetric analysis of SPRT: Concluding remarks  
For direct methods of measuring biomass concentration, determination of CDW by gravimetric 
analysis is best suited towards the morphological characteristics of SPRT. Results generated by 
vacuum filtration protocols showed a smaller variance than those generated by centrifugation 
owing to poor pellet formation. Discrete samples obtained by pipetting consistently showed an 
inherent sampling bias which lead to over-estimated CDWs. To obtain true and accurate CDW 
gravimetrically, whole contents of the flask sacrificed per data point, coupled with vacuum 
filtration and washing, should be used. It is important to have a standardised inoculum across 
all flasks when using the sacrificial flask approach.  
 
4.2 Chromatographic method development 
The development of chromatographic methods used a one-factor-at-a-time approach in which 
a single factor was altered to fine tune the method in a step-wise fashion. This approach, whilst 
tedious and neglecting the interaction between different variables, was helpful in fine tuning 
the methods to improve detection and resolution of compounds. Analysis of antimicrobial 
compounds produced by SPRT was done using chromatographic methods described by 
Le Roes (2006). The solvent extraction method used for obtaining antimicrobial compounds 
from SPRT cultures was adapted from Taddei et al. (2006) and is described in Section 3.3. 
Further method development was done to validate the protocols and presence of antimicrobials. 
Crude ethyl acetate extracts of SPRT cultures were filtered as used for analysis.  
 
4.2.1 Characterisation of antimicrobials: TLC 
Thin Layer Chromatography with Ultra Violet visualisation (TLC-UV) was used as quick tool 
to monitor the different groups of bioactive compounds present in the extracts. The aluminium 
backed silica plates were UV active, so compounds showed up as negative zones on 
chromatograms. A number of different solvent combinations were used as mobile phases. 
These are shown in Table 4.2. Mobile phase composition was varied according to polarity 
indices of the solvents.  For semi quantitative analysis when comparing samples, the same 
volume was spotted on plates, darker spots were taken to be indicative of higher quantity.   
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          Table 4.2 Composition of mobile phases used in TLC to separate bioactive compounds produced by SPRT. 
    Mobile Phase Solvent (%) 
A B C 
1 Chloroform     
  100     
2 Chloroform Acetic acid  
 90 10  
3 Chloroform Acetic Acid   
  10 90   
4 Ethyl Acetate Acetic Acid  
 90 10  
5 Ethyl Acetate DMSO   
  98 2   
6 Ethyl Acetate DMSO  
 90 10  
7 Ethyl Acetate Methanol   
  80 20   
9 Ethyl Acetate Methanol Acetic acid 
 80 18 2 
10 Ethyl Acetate Methanol Acetic Acid 
  90 9 1 
11 Ethyl Acetate Hexane Acetic acid 
 9 90 1 
12 Ethyl Acetate Hexane Acetic acid 
  90 9 1 
13 Ethyl Acetate Hexane Acetic acid 
 45 65 0.1 
14 Ethyl Acetate Hexane Acetic acid 
  9 90 1 
 
The majority of mobile phases (1, 2, 4, 5, 7 10, 11 and 12) used resulted in separation of the 
extract into 3 spots on the TLC plates. Mobile phases 3, 6 and 14 resulted in separation of the 
extract into 2 spots and no separation was achieved with mobile phase 13.  Plates developed 
with DMSO (5 and 6) were more prone to smearing and took up to 4 times longer to develop. 
In terms of  distance of spots from each other, the baseline and mobile phase front (resolution), 
mobile phases 4 and 12 produced the best separation  patterns and were used going forward 
(Section 5.5).  No further separation was observed when 2 mobile phases were used in tandem 
in 2 dimensional TLC. It is also noteworthy that no other spots were detected when plates were 
stained with the universal stains, anisaldehyde/H2SO4, vanillin/H2SO4 and cerium (IV) 
ammonium sulphate.   
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4.2.2 Characterisation of antimicrobials: HPLC  
High Performance Liquid Chromatography with Ultra Violet visualisation (HPLC-UV) was 
used to achieve greater separation of the antimicrobial extracts and to quantify compounds. 
HPLC with mass spectrometry (HPLC-MS) was used in an attempt to identify bioactive 
compounds. A wavelength scan of the antimicrobial extracts showed absorbance maxima at 
223 and 303 nm; whilst a scan of the pure solvent resulted in peak absorbance at 236 nm (Figure 
4.7). This helped inform the detection wavelength choice for HPLC-UV protocols investigated.  
Ethyl acetate is of medium polarity and favours extraction of polar and non-polar molecules 
alike hence the “crude” nature of the extracts. The marker molecule DPO is non-polar due to 
its ring structures (Figure 2.3) so reverse phase HPLC was deemed suitable for separation. Acid 
was included in the mobile phase to improve peak shape (reduce tailing) and assist with 
protonation in the ionisation step for MS. The various mobile phases, columns, flowrates and 
wavelengths investigated are shown in Table 4.3.  
 
 
Figure 4.7 Wavelength scans of a) ethyl acetate (solvent blank) b) ethyl acetate extract of SPRT culture (containing 
antimicrobials) 
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Table 4.3 HPLC conditions investigated for separation of bioactive compounds produced by SPRT. 
 
Method Column Time Flowrate Wavelength(s)
(min) A B (mL/min) (nm)
5% MeOH   
1% AA
95% MeOH 1%   
AA
1 C18 - Short* 0.0 0 100 0.5
22.0 0 100 0.5
2 C18 - Short 0.0 100 0 0.5
22.0 100 0 0.5
3 C18 - Short 0.0 50 50 0.5
45.0 50 50 0.5
4 C18 - Short ; 0.0 100 0 0.5
C18 - long** 2.0 100 0 0.5
30.0 0 100 0.5
32.0 100 0 0.5
5 C18 - long 0.0 100 0 0.75
2.0 100 0 0.75
30.0 0 100 0.75
40.0 100 0 0.75
6 C18 - long 0.0 100 0 0.5
2.0 100 0 0.5
30.0 0 100 0.5
38.0 0 100 0.5
40.0 100 0 0.5
7 C18 - long 0.0 70 30 0.75
2.0 70 30 0.75
30.0 0 100 0.75
30.1 0 100 0.75
46.0 0 100 0.75
46.1 70 30 0.75
50.0 70 30 0.75
8 C18 - long 0.0 100 0 0.75
2.0 100 0 0.75
2.1 80 20 0.75
7.1 80 20 0.75
7.2 60 40 0.75
12.2 60 40 0.75
12.3 40 60 0.75
17.3 40 60 0.75
17.4 20 80 0.75
22.4 20 80 0.75
22.5 10 90 0.75
27.5 10 90 0.75
27.6 0 100 0.75
44.0 0 100 0.75
44.1 100 0 0.75
50.0 100 0 0.75
303
303
303
Solvent (%)
216 ; 303
216 ; 303
303
303
303
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*    C18 – short = Phenominex luna c18 – 3 µ (2)   MeOH – Methanol 
**  C18 – long  = Phenomenex luna c18 – 5 µ (2)   AA     -  Acetic Acid 
Method Column Time Flowrate Wavelength(s)
(min) A B (mL/min) (nm)
5% MeOH   
1% AA
95% MeOH 1%   
AA
9 C18 - long 0.0 100 0 0.8
2.0 100 0 0.8
22.0 20 80 0.8
50.0 20 80 0.8
50.1 100 0 0.8
60.0 100 0 0.8
10 C18 - long 0.0 100 0 1
2.0 100 0 1
30.0 0 100 1
38.0 0 100 1
40.0 100 0 1
45.0 100 0 1
11 C18 - long 0.0 100 0 1
2.0 100 0 1
30.0 0 100 1
30.1 0 100 1
46.0 0 100 1
46.1 100 0 1
50.0 100 0 1
12 C18 - long 0.0 100 0 1
2.0 100 0 1
30.0 0 100 1
30.1 0 100 0.5
46.0 0 100 0.5
46.1 100 0 1
50.0 100 0 1
13 C18 - long 0.0 80 20 0.8 303
1.0 80 20 0.8
41.0 0 100 0.8
61.0 0 100 0.8
61.1 80 20 0.8
66.0 80 20 0.8
0.1%  
Formic 
Acid
100% 
Acetonitrile
14 C18 - long 0.0 98 2 1
22.0 0 100 1
27.0 0 100 1
28.0 98 2 1
35.0 2 98 1
210 ; 254 ;       
280 ; 303
Solvent (%)
303
303
303
303
Chapter 4                                                                                             Development of Methods  
Page | 45  
   
Isocratic method (Methods 1 – 3 Table 4.3) did not result in compound separation, with the 
chromatograms showing just a single peak. Gradient elution was used in methods 4 – 14. 
Increasing the run time and column length whilst making adjustments to the flow rate, as well 
as the gradient elution profile resulted in noticeable separation of the antimicrobial extract. 
Further adjustments to the gradient profile, most notably an increase in the hold time, improved 
peak sharpness and resolution. Of the protocols investigated, the most suitable methods were 
methods 13 and 14 which were used going forward for HPLC-UV and HPLC-MS, respectively. 
HPLC-UV and HPLC-MS analyses were done at different facilities hence the change in LC 
protocols.  
 
Separation of the antimicrobial extract by HPLC-UV produced several peaks (Figure 4.8), 
showing more efficient separation than TLC-UV (3 spots). Achieving a good baseline and 
resolution of peaks in HPLC-UV chromatograms was challenging. This was attributed to the 
crude nature of the extract. Identification of DPO peak was made by comparing the 
chromatogram of the antimicrobial extract with chromatograms generated by running a) the 
pure DPO compound and b) antimicrobial extract spiked with the pure DPO. The elution time 
for DPO was 19.1 minutes and 36.1 minutes for methods 13 and 14, respectively. Quantitative 
measurements were made by comparing peak areas with peak areas from a standard curve. 
Results showing production of antimicrobials by SPRT are shown in the next Chapter (Section 
5.6).  
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Chapter 5. Results and Discussion 
5.1 Introduction  
In order to scale-up a bioprocess successfully, it is important to understand the critical 
parameters affecting the system to provide the required environment at the larger scale (Katzer 
et al. 2001). The metabolic performance of microorganisms in submerged culture is highly 
dependent on the culture environment (Rahulan et al. 2011).   
 
The only published reports on the growth of Streptomyces polyantibioticus (SPRT) and its 
antimicrobial production are by Le Roes (2006) and Le Roes-Hill and Meyers (2009). Here the 
description of the organism, its characterisation and production of bioactive compounds by 10-
day old cultures of SPRT including 2,5-diphenyloxazole (DPO) is provided. Of the bioactive 
compounds produced by SPRT, DPO is the only identified compound. It is also produced in the 
highest quantities amongst the other antimicrobials (Le Roes 2006) and has shown potential 
for use as a new anti-tuberculosis drug. There is, however, an absence of bioprocess data, 
including kinetic data and data on response to process variables. In this study the submerged 
growth of SPRT, under batch conditions in shake flasks and stirred tank bioreactors, was 
investigated using the methods outlined in Chapters 3 and 4 to ascertain the time-based profiles 
of growth and antimicrobial product formation, the response to process variables and the basic 
kinetic parameters of DPO production. This was investigated to create a basis from which to 
assess potential for scale-up as an antimicrobial production process.  
 
5.2 Batch cultivation of SPRT in shake flasks 
The SPRT growth profile was determined in its production medium, Hacène’s medium, (HM; 
5.0 g/L glucose, 4.0 g/L yeast extract powder, 10.0 g/L malt extract and 1.0 g/L sodium 
chloride, pH 7.4) (Hacène and Lefebvre 1995; Le Roes 2006)  in shake flasks. The cultures 
were grown at a constant temperature of 28 °C, shaken at 170 rpm using a 10% (v/v) inoculum 
(Chapter 3.2.2). The full contents of one shake flask was sacrificed daily, per sample point, 
over a 10-day period. Biomass concentration and pH were measured throughout the 
experiment. The data are presented in Figures 5.1 and 5.2. 
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The SPRT culture did not exhibit a lag phase, with growth phase and maximum biomass 
concentration achieved in less than 50 hours (Figure 5.1). The highest biomass concentration 
obtained was 3.30 g/L, while the lowest pH of 5.28 was recorded after 24 hours of cultivation. 
The cell dry weight (CDW) decreased gradually at a rate of 0.146 g/day for the remainder of 
the cultivation, whereas pH increased sharply over the next 24 hours to a pH value of 7.94. 
Complete glucose depletion was observed at 50 hours, but based on the glucose utilisation rate 
and reaching the maximum biomass concentration around 24 hours, complete glucose 
depletion is postulated to have occurred between 26-30 hours (after extrapolating consumption 
rate in Figure 5.1). Biomass production appeared to be limited by both pH and carbon 
availability.  
 
The biomass data in Figure 5.1 does not provide a clear depiction of the growth phase, as it 
occurred between two sampling times. This necessitated further experimentation focussing on 
the growth phase. These growth experiments confirmed that the SPRT culture grown under 
these conditions adapted quickly, with a lag phase of not more than 3 hours (Figure 5.2A). A 
maximum specific growth rate of 0.260 h-1 was determined from the logarithmic plot of 
biomass as a function of time (Figure 5.2B), assuming exponential growth, according to the 
equation:  
dX
dt
  =  µX     ……………………………………………………. (Equation 2) 
  
 lnX =  µt      ……………………………………………………. (Equation 3) 
 
The exponential growth phase was supported between 3 and 9 hours, where after µ decreased 
with decreasing glucose availability.  
 
Reproducibility of biomass measurements was described in Section 4.1. The reproducibility of 
the biomass growth was evaluated by performing the growth experiment in triplicate under 
identical conditions.  The biomass profiles are displayed in Figure 5.3. The maximum biomass 
concentrations of 3.30, 3.00 and 3.01 g/L for cultures 1, 2 and 3, respectively, were obtained 
after 24 hours of cultivation. Again, assuming logarithmic growth (using Equations 2 and 3), 
maximum specific growth rates of 0.21, 0.26 and 0.20 h-1 were determined. The cultures also 
exhibited the same pH profiles, with a decrease in pH from pH 7.0 to below pH 6.0 coinciding 
with the formation of biomass (refer to Appendix D for summarised data). 
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Figure 5.1 Batch cultivation of SPRT grown in shake-flasks containing Hacène ’s medium, incubated at 28 °C and 170 rpm,  
displaying biomass production, glucose utilisation and the pH profile.  Profiles shown represent average values 
obtained from triplicate experiments; error bars represent standard error of the mean. 
 
 
Figure 5.2 Batch cultivation of SPRT grown in shake-flasks containing Hacène ’s medium, incubated at 28 °C and 170 rpm. 
Biomass production is displayed as cell dry weight (CDW) (A), with a natural log plot displaying a short lag phase 
(< 3 h) (B). Profiles shown represent average values obtained from duplicate experiments; error bars were 
calculated using standard deviation.  
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Figure 5.3 Batch cultivation of SPRT grown in shake flasks showing A) biomass production (open markers = CDW, solid 
markers = natural log of CDW) and B) pH profile. Cultures were grown in Hacène’s medium at 28 °C and 170 
rpm. Data points shown represent the average obtained from triplicate experiments (whole flasks sacrificed); error 
bars represent one standard deviation from the mean (note some symbols are larger than error bars). 
 
5.3 Effect of glucose supply on SPRT cultures  
Hacène’s medium is comprised of glucose, malt extract, yeast extract and salt (NaCl) in 
concentrations of 5, 10, 4 and 1 g/L, respectively. The glucose is the most readily available 
carbon source for SPRT to utilise, with more complex carbon available as oligomers of glucose 
and as peptides and proteins in malt and yeast extract. To test whether glucose availability in 
the medium was limiting biomass production, cultures grown in Hacène’s medium with 
differing initial glucose concentrations were compared (Figure 5.4).  Furthermore the effect of 
glycerol addition to the medium on biomass production was investigated. Samples were 
retained for DPO analysis, which is presented in Section 5.5. 
 
Despite differing glucose and glycerol concentrations, each culture exhibited a similar growth 
profile (Figure 5.4A) and produced similar maximum biomass concentrations of 3.04, 2.90, 
3.46 and 3.48 g/L for cultures H5 (5 g/L glucose), H10 (10 g/L glucose), H20 (20 g/L glucose) 
and HGLY (5 g/L glucose and glycerol) respectively. The amount of glucose consumed over 
time is shown in Figure 5.4B. Over the first 25 hours, the glucose utilisation rate was 0.25, 
0.20, 0.30 and 0.16 gglucose/h for H5, H10, H20 and HGLY. The biomass yield in this time was 
similar for cultures H5, H10 and H20 (0.49, 0.54 and 0.46 gbiomass/gglucose) but was slightly 
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elevated for the HGLY culture (0.78 gbiomass/gglucose). After 51 hours, the glucose in H5 and 
HGLY cultures was completely exhausted, the H10 culture had 0.69 g/L remaining and the 
H20 culture still contained just over half (10.99 g/L) the initial starting glucose concentration. 
Cultures H10 and H20 continued to consume glucose at the same rate, even after having 
attained maximum biomass concentration. This only occurred at high glucose concentration 
and may be attributed to the production of an extracellular product such as extracellular 
polymeric substances (EPS) and volatile fatty acids (VFA’s). Accumulation of EPS substances 
could also explain the increase in pH following the initial pH drop, caused by the metabolism 
of glucose in the medium. Whilst similar trends in pH were observed with an initial decrease 
over the first ten hours followed by an increase, the pH of cultures H10, H20 and HGLY only 
returned to the starting pH after 51 hours. Conversely, cultures grown in regular Hacène’s (H5) 
experienced a sharper pH increase and were two pH units above the starting value after 51 
hours (Figure 5.4C).  
 
5.4 Batch cultivation of SPRT in a lab scale STR 
There are many reactor types, both conventional and unconventional in which microbial 
cultivation can occur. Considering the absence of literature on SPRT cultivation in vessels other 
than a shake flask, reactor choice was decided by considering other streptomycete cultures. The 
two reactor types that are used for the cultivation of streptomycetes are stirred tank bioreactors 
(STR) and bubble columns. The most common bioreactors for commercial production of 
commodity products are mechanically agitated stirred tank reactors (Erickson 2011); notably, 
preferred industrial hosts Streptomyces coelicolor and Streptomyces lividans are grown in a 
STR (van Wezel et al. 2006).  Batch cultivations in this study were thus performed in a lab 
scale STR’s. This vessel was chosen based on the ease of measurements, close control over 
process parameters and comparatively good mixing leading to increased homogeneity.  
 
Batch experiments with SPRT in HM were performed in a 7-L New Brunswick bioreactor, 
described in Section 3.2.3, using a 3-litre working volume with the aim of up-scaling the shake 
flask process described in Section 5.3. The growth profile and basic kinetic parameters were 
determined for each run. The initial run is described in Section 5.4.1, where notably severe 
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foaming and wall growth was encountered. Section 5.4.2 describes the steps taken to overcome 
the foaming and displays the growth profiles of experiments leading to a foam free run.   
 
 
 
5.4.1 Reference case batch STR cultivation:  Experiment A 
SPRT inoculum was prepared in the same manner as the SF experiments, with an additional 
inoculum step included to raise biomass (Figure 5.5) as described in Section 3.2.3. The culture 
system parameters outlined in Table 5.1 were used.  Biomass concentration (CDW), pH and 
dissolved oxygen concentration (DO) were measured throughout the experiment. Samples 
were also tested for DPO and other antimicrobials, as shown in Section 5.6. The experiment 
was terminated after 6 days; the time profiles of the first 25 hours of the culture are shown in 
Figure 5.6A. 
 
 
Figure 5.5 Inoculum train used in bioreactor studies.   
 
Table 5.1 System parameters used in initial unstable STR growth experiment 
Parameter  Setting 
Culture volume  3 L            (unmaintained) 
Agitation 400 rpm    (constant) 
Aeration, (air) 1 vvm 
Temperature 28 °C        (constant) 
pH  7.4            (uncontrolled) 
Medium Hacène’s   (5.0 g/L glucose, 4.0 g/L yeast extract powder, 10.0                       g/L malt extract and 1.0 g/L sodium chloride, pH 7.4) 
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The SPRT culture exhibited no noticeable lag phase with an immediate exponential increase in 
cell dry weight and reduction in dissolved oxygen. Exponential growth continued for 
12.5 hours with a specific growth rate of 0.246 h-1. Growth slowed substantially as the culture 
depleted the glucose and entered stationary phase. A maximum cell dry weight of 6.24 g/L was 
obtained after 18 hours. Culture pH remained neutral for the first 8 hours and then began to 
steadily decline until reaching a minimum at pH 5.28 after 18 hours, after which it rose back 
to the starting pH. Glucose was largely utilised after 18.5 hours, with a constant residual 
concentration of <0.5 g/L remaining. Towards the end of the exponential growth period the 
culture began to foam, severely compromising the experiment. This resulted in clogged filters 
and excessive wall growth. After 20 hours of cultivation the outlet air filters were replaced, 
aeration and agitation were reduced to 0.5 vvm and 200 rpm, respectively, for the remainder of 
the experiment (124 hours), but did not result in the alleviation of foaming. The excessive 
foaming resulted in difficulties in containment and analysis; hence, early termination of the 
experiment was necessary. 
5.4.2 Foam mitigation in STR: Experiments B – D 
Two main strategies were employed to reduce the foaming in subsequent bioreactor 
cultivations. These were the addition of antifoam and the use of a mechanical foam breaker. 
Adjustments to the bioreactor set up and operating procedure were also made, as described in 
Table 5.2, below. Each experiment was performed in duplicate bioreactor cultivations, using 
Experiment A as the reference cultivation (Section 5.4.1). 
 
The strategy adopted in Experiment B was a reduction in aeration rate from 1 to 0.75 vvm, a 
change in agitation regime to maintain a DO concentration above 40% and the inclusion of 
0.075 % antifoam (Antifoam 204) in the medium. Additionally, water was sprayed directly 
(from above through a port on head plate) to suppress the formation of the foam head. In 
Experiment C, physical modifications were made to the bioreactor set up with depth filters 
fitted to the air outlet (as opposed to the absolute (membrane) filter used previously) and a 
mechanical foam breaker to the agitation shaft. The culture volume was also maintained by 
replacing volume lost due to sampling with an equivalent amount of water. In Experiment D, 
pH control was implemented with culture pH maintained at 6.5-7.6, using 5M HCl and 5M 
KOH. Time profiles showing the first 25 hours of cultivations are shown in Figure 5.6. The 
basic kinetic parameters are shown in Table 5.3. 
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Excessive foaming and wall growth resulting in early termination occurred in Experiment A, 
B and C. Despite the foam mitigating strategies employed in Experiment B, the onset of 
excessive foaming occurred after 13 hours; 5 hours earlier than in Experiment A. Increasing 
the initial antifoam dosage from 0.075% to 0.1% and the mechanical modifications added in 
Experiment C did not alleviate foaming and excessive foaming occurred after 18 hours.  
 
A stable run was achieved with pH control in Experiment D, with runs lasting the full duration 
of the 10-day experiment. Maintaining a pH between 6.5 - 7.6 in Experiment D contributed to 
a stable run by ensuring some of the surface active compounds (likely proteins) remained 
soluble in the media (Junker 2007). Antifoam addition to the starting medium, as well as drop-
wise addition was needed during the experiment. Adjustments to the aeration, pH and agitation 
regimes reduced the total amount of antifoam needed to achieve a stable run (12ml in 
experiment B to 5.5 ml in experiment D). Samples were reserved for DPO analysis (Section 
5.5).  
 
Stable cultures (as demonstrated in Experiment D, figure 5.6) experienced a lag phase of under 
3 hours, biomass increased exponentially with a µmax of 0.27 h-1 until 12 hours before the 
culture entered stationary phase. The biomass concentration peaked at 3.53 g/L after 14 hours, 
and glucose was largely depleted after 18.5 hours, with a residual glucose concentration of 1.04 
g/L. For the first 16 hours, agitation was increased stepwise from 250 to 600 rpm to ensure a 
dissolved oxygen content of greater than 40%. Agitation was maintained until day 4, primarily 
to ensure that mild foaming could be controlled by the mechanical foam breaker. Agitation was 
then stepped down to 300 rpm for the remainder of the experiment (a further 6 days).  
 
5.5   Production of DPO and other bioactive compounds by SPRT 
SPRT cultures (from plates and shake flasks) were subjected to a series of antimicrobial activity 
tests to validate its capacity for bioactive compound production, including that of DPO, as first 
reported by Le Roes (2006). This was investigated by the use of agar overlays and spot test 
bioautography.  Table 5.4 shows the results of these antimicrobial activity tests using 
Mycobacterium aurum, Escherichia coli and Staphylococcus aureus as test bacterium. SPRT 
showed diverse bioactivity by yielding positive results against all test bacterium, which is 
consistent with activity reported by Le Roes (2006). SPRT demonstrated its potential for 
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producing anti-TB antimicrobials by the positive activity against M. aurum, a bacterium with 
a similar susceptibility profile as M. tuberculosis. SPRT also demonstrated that it could produce 
antimicrobials under both submerged and solid state growth conditions. 
 
Table 5.4 Bioactivity tests carried out on compounds produced by SPRT. 
 
 ‘+++’  = Strongly positive;   ‘ +’     = weakly positive;  ‘–‘     = negative  
 All extracts were ethyl acetate based. 
 
Ethyl acetate extracts from 10-day shake flask cultures were separated using thin layer 
chromatography (TLC). TLC chromatograms were visualised using ultraviolet light (TLC-UV) 
and bioautography (TLC-B). The use of general visualising agents, (anisaldehyde/H2SO4, 
vanillin/H2SO4 and cerium (IV) ammonium sulphate) was deemed unnecessary as described in 
the method development (Section 4.2.1). These extracts showed 3 distinct groups of spots with 
retention factors (Rf) of 0.42, 0.81, 0.94 when a mobile phase of ethyl acetate and acetic acid 
(90:10) was used. Spots had Rf  of 0.79, 0.48 and 0.07 for mobile phase with ethyl acetate, 
hexane and acetic acid (90:9:1), an example of which is shown in Figure 5.7. The polarity of 
the spots can be induced from the spot Rf , with the more polar molecules (demarcated C, Figure 
5.7) having low Rf and the more non polar molecules (demarcated A and B, Figure 5.7) having  
higher Rf. DPO was shown to be present in the extract by running the pure standard and spiked 
extract (Lanes 1 and 3, Figure 5.7) under the same conditions, confirming DPO production by 
SPRT. It was noted that DPO in the extract had a slightly different Rf than the pure compound, 
this was likely due to some interaction(s) with other compounds in the extract (Snell et al. 
1956). The presence of DPO in the samples was further confirmed by mass spectrometry as 
shown in Figure 5.8. This figure shows an ion extracted chromatogram peak at a mass charge 
(m/z) ratio of 222.0853 (the molecular weight of DPO) and mass spectral analysis at 19.1 min 
(the expected DPO elution time).DPO production by SPRT in shake flask cultures was 
quantified using HPLC. The time based profiles are shown in Figure 5.9. DPO concentration 
M. aurum E. coli  S. aureus
day 5 day 10 day 5 day 10 day 5 day 10 day 10 day 10 day 10
Stab innoculted SPR Agar plate - +++ - ++ - ++
Extract of SPR Agar plate culture - - - - - + + - -
Extract of SF -  Mycelial Mass + ++ - + - + ++ + +
Extract of SF -  Liquid filtrate - + - + - + + + -
Extract of SF -  Whole culture + ++ - + + ++ +++ ++ +
M. aurum E. coli  S. aureus
Sloppy Agar overlays  
Source
Spot test  Bioautography
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increased with increasing biomass concentration, and after 26 hours, 272 ± 40.45 µg per litre 
of SPRT culture was achieved.  Ethyl acetate extracts from the bioreactor samples exhibited the 
same TLC-UV spot patterns as extracts from the shake flask and agar cultures, but yielded 
weakly positive results (extracts needed to be concentrated  >100x than those from the shake 
flasks). A summary of results are shown in Table 5.5. The DPO in the bioreactor extracts was 
not quantifiable by HPLC despite ‘spot A’ being present on TLC chromatograms. 
 
 
 
Figure 5.7 Thin layer chromatogram of SPRT shake flask extracts developed using ethyl acetate, hexane and acetic acid (90:9:1 
v/v) as mobile phase. Three lanes are shown, 1) DPO standard, 2) Shake flask extract (t=10d) and 3) Shake flask 
extract (t=10) spiked with DPO standard.  
 
C
ha
pt
er
 5
 
 R
es
ul
ts
 a
nd
 D
is
cu
ss
io
n 
P
ag
e 
| 
6
0
 
5
10
15
20
25
30
Tim
e [
min
]
0.00.20.40.60.81.0
4
x1
0
Int
en
s.
F1
A_
RA
1_
01
_1
34
2.d
: E
IC 
22
2.0
00
0 +
All
 M
S
98
.50
87
11
3.9
61
2
14
1.9
53
7
15
9.9
64
7
22
2.0
85
3
24
5.2
21
9
26
8.2
37
6
29
1.2
06
6
33
2.3
22
9
36
9.2
52
1
+M
S, 
19
.1m
in #
11
23
051015
Inte
ns
.
[%
]
50
10
0
15
0
20
0
25
0
30
0
35
0
m/z
D
P
O
   
   
 
t=
1
9
.1
 
m
in
 
D
P
O
O
 F
ig
ur
e 
5.
8 
Io
n 
ex
tra
ct
ed
 c
hr
om
at
og
ra
m
 a
nd
 m
as
s c
hr
om
at
og
ra
m
 o
f e
th
yl
 a
ce
ta
te
 e
xt
ra
ct
ed
 sh
ak
e 
fla
sk
 c
ul
tu
re
 o
f S
PR
 c
on
fir
m
in
g 
pr
od
uc
tio
n 
of
 D
PO
 (M
r –
 2
21
). 
Chapter 5                                                                                                Results and Discussion  
Page | 61  
 
 
 
Figure 5.9 Profile of biomass and DPO production in shake flasks of SPRT in HM, at 28 °C and 170 rpm 
 
 
 
Table 5.5 TLC bands present in ethyl acetate extracts of SPRT cultures. 
    Shake Flask 
STR -         
Expt A 
STR -         
Expt B 
STR -         
Expt C 
STR -     
Expt D 
‘A’              
Rf = 0.79 
day 1     x 
day 10  n/a n/a n/a  
‘B’                                
Rf = 0.48 
day 1     x 
day 10  n/a n/a n/a  
‘C’                                
Rf = 0.07 
day 1     x 
day 10  n/a n/a n/a  
 
 = present,              x = absent,                   n/a = no test – experiment terminated before day 10  
 
5.5.1 Effect of initial glucose supply on the production of DPO and other bioactive 
compounds 
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The medium was modified to increase glucose concentration and explore the addition of 
glycerol to look at the effect on DPO production. Shake flask cultures grown in Hacène’s 
medium with differing initial glucose concentrations (from Section 5.3) were extracted with 
ethyl acetate and compared. with TLC chromatograms of cultures grown in modified media 
(H10, H20 and HGLY) did not show any spots. TLC chromatograms of cultures grown in 
conventional Hacène’s medium (H5) had the same spot patterns as above (Figure 5.7). 
 
5.5.2 Effect of temperature on the production of DPO and other bioactive compounds  
To assess the effect of temperature on the production of DPO and other bioactive compounds, 
SPRT was grown in a stirred tank bioreactor to mid exponential growth phase (t = 15 h). This 
culture was aliquoted and transferred to shake flask cultures aseptically. The cultures were 
incubated at a range of temperatures (20, 30, 37 and 45 °C). Two flasks were sacrificed at each 
time point (0, 3, 6 and 10 days following transfer) for biomass and bioactive compound 
analysis. Figure 5.10 shows the change in biomass over the time (refer to Appendix F for raw 
data). After 3 days the cultures incubated at 30 and 37 °C had biomass concentrations of 5.37  
± 0.001 g/L and 5.23 ± 0.003 g/L, this was higher than cultures incubated at 20 and 45 °C 
which had 3.74 ± 0.300 g/L and 3.86 ± 0.000 g/L, respectively. 
 
Ethyl acetate extracts of the aforementioned shake flask cultures contained three groups of 
bioactive compounds, across all temperatures, when separated by TLC-UV. Figure 5.11 shows 
the separation of these compounds into 3 bands A, B and C (Rf 0.94, 0.81 and 0.42 
respectively). Results were interpreted semi quantitatively by assigning a score to spot 
densities. Negative results were given a score of 0 and positive scores graded at either 30, 60 
or 90. Spot intensity in relation to the temperature at which SPRT was grown are shown in 
Figure 5.12 across the time profile of the cultures. Antimicrobials were produced to a maximum 
between days 0 and 3 following transition in temperature after the 15 h biomass cultivation in 
STR. Variations in the relative ratios of the antimicrobial metabolites as a function of 
temperature were observed. Compound A, containing DPO, was favoured at 20 and 30 C, 
whereas compound B and C were favoured at 45 and 37 C, respectively. In all cases, titres 
remained very low and not quantifiable by HPLC.  
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Figure 5.10 Time based profile of SPRT cultures in shake flask cultivated in Hacène’s medium and shaken at 170 rpm, 
following transfer from exponential phase STR culture. Error bars represent standard error of the mean (n=2). 
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Figure 5.12 Semi-quantitative interpretation of TLC results (Figure 5.11) for the effect of temperature on bioactive products, 
A (DPO), B and C, produced by shake flask cultures of SPRT following transfer from exponential phase STR 
culture. Weakly, moderately and strongly positive results were graded 30, 60 and 90 respectively. Negative results 
are scored as 0.   
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5.6   General discussion 
5.6.1 SPRT growth and production of antimicrobials in shake flasks:  a reference case    
SPRT is a filamentous microbe which grows by tip extension of its hyphae. This differs from 
growth of other bacteria and fungi which grow by fission and budding, respectively. When 
cultivated in liquid culture, filamentous microbes, such as SPRT, exhibit morphologies ranging 
from homogenous, dispersed mycelia to discrete compact pellets (Tough and Prosser 1996). 
This can often lead to difficulties in measurement of biomass concentration and result in 
variable growth. Shake flask cultures used in the present study consistently grew at a maximum 
specific rate of 0.260 h-1, achieving maximum biomass concentrations of 3.10 ± 0.098 g/L. 
This maximum biomass concentration was not limited by glucose availability because it was 
reached prior to glucose depletion (Figure 5.4). It is recommended that the potential of other 
limiting nutrients or growth factors be explored. 
 
Antimicrobial activity was confirmed towards M. aurum, E. coli and S. aureus using bacterial 
overlay plates. TLC results from shake flasks confirmed the production of DPO (contained in 
spot A, Figure 5.7) and 2 other un-identified groups of antimicrobials (spots B and C in Figure 
5.7). Spots A and B were fairly non polar, based on their proximity to the solvent front (high 
Rf), a property typical of Type II aromatic polyketide antibiotics. Spot C contained molecules 
significantly more polar than A and B because they adhered strongly to the TLC plate (low Rf). 
From this one can infer that Spot C likely contained polar compound(s) such as aldehydes, 
ketones, carboxylic acids, amines and or alcohols.  
 
DPO production was growth associated, increasing as the biomass concentration increased 
(Figure 5.9). It was, however, only produced at low levels in this study, with a maximum of 
286 µg/L (0.11 µg/mgcells), which is significantly lower than the 24 400 µg/L previously 
reported by Le Roes (2006) at 10 days. No improvement in the DPO content, or that of other 
antimicrobials, was seen by increasing the stationary phase time of the culture. This is unusual 
considering that antimicrobials are typically reported as secondary metabolites (Bibb 2005; 
Zhu et al. 2014). Growth-associated production of antimicrobials, whilst unusual, is not 
unprecedented with similar growth associated production of undecylprodigiosin (5-
60 µg/mgcells) by Streptomyces coelicolor reported by Hobbs et al. (1990). Results from the 
present study showed growth associated production to lower levels plateauing at day 3. 
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Similarly, Hobbs et al (1990) also showed that this growth association was not constitutive, 
since no production was observed in altered media. The low titres could be explained by genetic 
instability (loss in virility), a down regulation of the responsible genes (Hranueli et al. 1995; 
Yagüe et al. 2012) or some combination. Domesticated laboratory strains typically experience 
a reduction in production titres due to a lack of selective pressure. Non defined media, like 
Hacène’s used in the present study, have variable constituents and even small changes to media 
contents can affect antimicrobial production (Iwai and Omura 1982)  Whilst not absolute, 
correlation has been made between mycelial morphology and secondary metabolite production 
(Yagüe et al. 2012). However, in this case this phenomenon does not account for differences 
in DPO production observed in this study and those by Le Roes (2006) as morphology type 
was maintained.  
 
5.6.2 SPRT growth and production of antimicrobials in a stirred tank bioreactor: shake 
flask parallels and challenges of scale-up.   
Both the shake flask and bioreactor cultures exhibited non-homogenous pelleted morphologies. 
Biomass concentration profiles as a function of time over a ten day cultivation period showed 
SPRT cultures exhibited exponential growth, stationary and death phases. Shake flask (SF) and 
stirred tank bioreactor (STR) cultures exhibited similar growth profiles and basic growth 
kinetics. The lag phase lasted not more than 3 hours in both the SF and STRs. During the 
growth phase, which lasted for 15 and 12 hours, biomass increased exponentially at a rate of 
0.260 h-1 and 0.266 ± 0.002 h-1 for SF and stable STR cultures (Expt D), respectively. The 
maximum biomass achieved was 3.10 ± 0.098 g/L and 3.53 ± 0.000 g/L.  
 
Whilst similar growth, morphology and yields were achieved in both reference shake flask 
experiments and stable stirred tank bioreactors, only negligible amounts of DPO and other 
antimicrobials were produced in the STR experiments. This was true across all bioreactor 
experiments, regardless of whether excessive foaming was experienced. The differences in the 
growth environment in the STR as compared to the SF was the likely cause for the low titres 
of antimicrobial compounds. This also suggested that a trigger is needed for production of 
antimicrobials (see section 5.6.3). The major differences between shake flasks and stirred tank 
bioreactors are agitation and aeration, which may have contributed to the lack of antimicrobials 
being produced. High agitation rates required to mix the culture and mitigate foaming provide 
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a high shear environment. Additionally the antifoam included in the bioreactor runs B – D 
added an additional barrier to mass transfer of nutrients and gases.  
   
Excessive foaming occurred in stirred tank bioreactor experiments A – C (Section 5.4), forcing 
experimental runs to end prematurely. The foaming resulted in a non-homogenous system. 
Liquid was trapped in the foam layer whereas the biomass partitioned to the bulk media 
resulting in a more concentrated microbial suspension in the bulk medium. This was evident in 
Experiment A where the biomass concentration of the bulk liquid reached 6.24 g/L, which is 
almost double the biomass yield experienced in all the other shake flask and stirred tank 
bioreactor experiments (Table 5.3). Furthermore, biomass was deposited on the walls, 
impellers and probes. The resultant biofilms clogged air filters and interfered with probes, thus 
increasing the back-pressure. Inoperable conditions were created where sampling became non-
representative due to non-uniform biomass distribution. This is evident in the rapid fall and 
erratic biomass concentrations recorded post commencement of excessive foam (Figure 5.6). 
Measurements of dissolved oxygen and pH became less reliable due to compromised 
monitoring equipment (fouling of probes) and liquid containment is an issue due to rising foam 
and liquid levels. Not only were conditions inoperable, they also created conditions of nutrient 
limitation for the culture. High biomass in the bulk medium quickly deplete nutrients, whilst 
biomass present as wall growth has limited access to the nutrients in the liquid medium (Junker 
2007). Conditions of nutrient limitation are typically conducive to production of secondary 
metabolites, including antimicrobials (Coze et al. 2013); however, all stirred tank bioreactor 
experiments showed negligible amounts of DPO and other bioactive metabolites (Section 5.5). 
TLC-UV results of the undiluted crude extracts tested negative and weakly positive after being 
concentrated 100-fold.  
 
Since the factors affecting foam formation (discussed in Section 2.7) are many and often 
complexly interdependent, the foam mitigation strategy employed (Experiments B-D, section 
5.4) was multifaceted. Careful control of the pH, aeration rate, agitation rate, antifoam addition 
and pH control was used to create a stable run (Experiment D). Decreasing the aeration rate 
decreased the amount of gas bubbles erupting from the liquid surface contributing to foam 
build up (Van’t Riet and Tramper 1991; Vardar-Sukan, 1991).  
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Agitation control was tricky, with the agitation rate having convoluted consequences. 
Increasing agitation rate, increased foaming, due to higher gas entrainment. However, high 
agitation was needed during the growth phase in order to provide sufficient mass transfer and 
to maintain the DO content above 40%. Using a stepped agitation protocol to maintain the DO 
concentration ensured the agitation was not higher than needed. Conversely, agitation can be 
used to mitigate foam. In the present study it was observed that very high agitation rates 
(>600rpm) decreased foaming, due to mechanical disturbance. Stirring as a form of foam 
disruption (SAFD) was further aided by inclusion of a mechanical foam breaker to the agitation 
shaft. Use of high agitation rates was avoided since this creates an environment of high shear, 
which adversely affects the metabolism of microbes, especially filamentous microbes. High 
shear stress also promotes lysis which releases cell contents, increasing the foaming potential 
of the culture, by increasing the concentration of surface active compounds (mostly proteins) 
in the medium. 
 
5.6.3 Stimulating production of antimicrobials  
Single parameter alterations to growth conditions have been shown to elicit responses resulting 
in increased yields of secondary metabolites, as well as to stimulate production of ‘cryptic’ 
metabolites previously not produced (Bode et al. 2002; Zhu et al. 2014; Bertrand et al. 2014; 
Yoon and Nodwell 2014; Imai et al. 2015). In order to explore increasing levels of bioactive 
metabolites obtained by SPRT cultures, experiments were undertaken in which the starting 
glucose concentration in the production medium and the cultivation temperatures were varied. 
This was to be investigated by either increasing the machinery (biomass) available, increasing 
the inputs (feeding more substrate) or activating production (stress response) or some 
combination of the above (Zhu et al. 2014; Yoon and Nodwell 2014).  
 
The shake flask growth profiles (Section 5.2) showed a simultaneous increase in biomass 
concentration and decrease in glucose concentration with time, with cessation of growth 
coinciding with glucose depletion to less than 1 g/L. Yeast extract and malt extract provide 
alternative organic carbon sources in the form of  larger reducing sugars (mostly maltose) and 
some proteins (Heron 1966). Malt extract in Hacène’s medium (10 g/L) provides an additional 
~12 g/L of glucose equivalents (Sigma reports malt extract at ~60% maltose). However, despite 
most streptomycetes being able to metabolise maltose (van Wezel et al. 1997), no further 
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increase in biomass was observed over 240 h.  This suggested that glucose may be growth 
limiting for SPRT. To investigate this, the starting glucose concentration was increased 2- and 
4- fold with the aim of achieving higher biomass concentrations and higher titres of bioactive 
metabolites. The results reported in Figure 5.4 showed that, despite increasing the initial 
glucose concentration in the medium, the maximum biomass concentration obtained was 
largely unchanged at 3.04, 2.90 ± 0.10 and 3.46 g/L dry mass achieved from 5, 10 and 20 g/L 
glucose, respectively. Similarly, no further increase in biomass was attained nor diauxic growth 
observed in cultures grown with 5 g/L glucose and 5 g/L glycerol in the medium for which a 
maximum biomass concentration of 3.48 ± 0.26 g/L was obtained. For the first 23 h  Yx/s, glucose 
is 0.49 , 0.54 and 0.46 gx/gs for H5, H10 and H20 cultures. Between 23 h and 51 h there is no 
increase in the biomass concentration, yet the utilisation rate of the residual glucose in the 
cultures H10 and H20 remained unchanged. This indicated that there was a change in 
metabolism where other additional product(s) were being produced in place of biomass 
production, this was only observed in cultures with excess glucose concentration.  
 
Furthermore, the culture extracts tested negative for bioactive products in the altered medium 
despite the additional carbon being available. These findings indicate that, on increasing carbon 
availability, biomass formation ceased in the presence of residual glucose, i.e carbon was no 
longer growth limiting. Growth limitation may have resulted from insufficient nitrogen, some 
trace element or the initial pH decrease experienced by the cultures. The lack of DPO and other 
bioactive molecules in the cultures provide evidence supporting glucose related secondary 
metabolite regulation.  
 
To investigate triggering increased bioactive metabolite titres as a stress response, SPRT was 
subjected to temperature fluctuations following cultivation (Section 5.6.1).  In all cases titres 
produced remained very low and not quantifiable by HPLC. However TLC results did show 
that there were slight variations in the relative ratios of the antimicrobial metabolites as a 
function of temperature. Compound A, containing DPO, was favoured at 20 and 30 C, whereas 
compound B and C were favoured at 45 and 37 C, respectively (Figure 5.14). Antimicrobials 
were produced to a maximum between days 0 and 3 following transition in temperature after 
the 15 h biomass cultivation.  Regardless of temperature, the bioactive metabolites detected 
either remained at a similar level or decreased between day 3 and 10. Antimicrobials were 
produced only in the shake flasks. The highest temperature (45°C) gave the highest total 
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antimicrobial concentration. This improved performance at higher temperature is consistent 
with Yoon and Nodwell (2014) who reported an increase in jadomycin B production by 
Streptomyces venezuela, following a temperature shift from 27 to 42°C. 
 
Results from the above mentioned production stimulation experiments conducted in the present 
study showed that increasing the starting glucose concentrations can globally down-regulate 
antimicrobial production, possibly through some mechanism of carbon catabolite repression or 
the Crabtree effect. They also show differential activation of antimicrobial production via some 
temperature dependent mechanism. Further, the physio-chemical conditions present in the 
bioreactor environment appeared to inhibit antimicrobial production. These suggest that there 
are multiple levels of regulation dependent on different external stimuli. To fully understand 
this, further investigation of the internal metabolic pathways for production of antimicrobials 
in SPRT is required.  
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Chapter 6. Conclusions and Recommendations 
6.1 Conclusions 
Resistance to antibiotics by microbial pathogens continues to be a major global health problem 
and the discovery of novel antimicrobial molecules is important for disease control. The 
actinobacterium, Streptomyces polyantibioticus SPRT (SPRT) has been shown to produce 
bioactive molecules active against a range of bacteria. One such antimicrobial is 2,5-
diphenyloxazole (DPO), which has anti-tubercular properties (Le Roes 2006). Thus, SPRT has 
the potential to assist in abating antibiotic resistance by providing new antimicrobials. SPRT is 
the first reported biological source of DPO, providing an alternate to chemical synthesis, which 
involves multiple-step reaction schemes and harsh reaction conditions (Giddens et al. 2005; 
Wan et al. 2010; Xu et al. 2013).  
 
This study was done to investigate the growth of SPRT and the production of DPO and other 
bioactive molecules to provide biokinetic data. Further, the performance of SPRT in stirred tank 
bioreactors was investigated as a first step towards scale-up of production. Characterisation of 
the growth profile, determination of the kinetic growth parameters of SPRT and bioactive 
compound production phases, as well as investigation of factors influencing antimicrobial 
production were carried out. 
 
This study confirmed the production of multiple antimicrobial metabolites including that of 
DPO, albeit at a lower level, which is consistent with results by Le Roes (2006). The study 
provided additional process information including growth kinetics, and the effects of 
temperature and initial glucose concentration on both biomass and antimicrobial production. 
To achieve these outcomes, method development was required for reproducible determination 
of filamentous biomass concentration using gravimetric methods and quantitative 
determination of the DPO using HPLC. This study also outlined some process challenges 
associated with cultivation of filamentous bacteria in the stirred tank bioreactor. Limitations in 
sampling and measurements were addressed.  
 
 
From the experimental work done in the present study the following conclusions could be made 
with regards to the dissertation objectives: 
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Development of experimental procedure(s) that allowed characterisation and analysis of 
biomass and antimicrobial production profiles of SPRT. 
In order to achieve an acceptable level of reproducibility, optimisation of sampling approaches 
were required (Section 4.1). The most reliable method of biomass determination was by dry 
weight gravimetric measurement of the full contents of shake flasks following vacuum 
filtration. This was due to the filamentous nature of SPRT biomass in submerged culture and 
poor pellet formation when subjected to centrifugation. TLC following solvent extraction of 
SPRT culture was a useful tool for quick analysis of antimicrobials produced. Good separation 
of the antimicrobials into 3 spots, with minimal smearing, was achieved with 2 mobile phases: 
(i) ethyl acetate and acetic acid, 9:10 and (ii) ethyl acetate, hexane and acetic acid, 90:9:1.  A 
reverse-phase HPLC method using 23-95% methanol with 1% acetic acid at 0.8 mL/min on a 
40 min linear gradient with a 10 minute hold time was developed, which gave good resolution 
of DPO and other unidentified antimicrobials.      
 
Determination of the growth profile and maximum specific growth rate of SPRT under 
standard conditions and time of onset of antimicrobial production. 
Cultivation of SPRT in Hacène’s medium in shake flasks at 28 °C with agitation over 10 days 
yielded reproducible cell culture. The growth phase occurred over 12-15 hours at a maximum 
specific growth rate of 0.260 h-1, achieving a maximum biomass concentration of 3.30 ± 0.070 
g/L. Under conditions investigated, SPRT produced 3 sets of antimicrobials, including DPO, 
displaying activity against both gram negative (E. coli) and gram positive (S. aureus) bacteria. 
Antitubercular bioactivity was inferred from antimycobacterial activity displayed against M. 
aurum. The production of DPO and the other antimicrobials is facultatively growth associated. 
The DPO titre of 286 µg/L was significantly lower than the 24 400 µg/L previously reported 
by Le Roes (2006).  
 
Aerated stirred tank bioreactor growth of SPRT posed many challenges, the most prominent 
challenge being foaming. The addition of antifoam, foam breakers and pH control was 
necessary to alleviate foaming. Cultivation of SPRT in Hacène’s medium in aerated stirred tank 
bioreactors at 28 °C with aforementioned foam mitigation considerations over 10 days yielded 
reproducible cell culture with a maximum specific growth rate (0.266 ± 0.002 h-1), maximum 
CDW (3.53 g/L) and productivity (0.52 ±0.06 gx/gs) comparable to that of shake flask 
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cultivations. Production of DPO and other antimicrobials was not quantifiable by HPLC but 
were more than 100x lower than that produced by the shake flask cultures. The conditions used 
in the present stirred tank bioreactor experiments were not ideal for bioactive metabolite 
production by SPRT.  
 
Investigation of the change in growth and antimicrobial production of SPRT in response to 
modified glucose concentration in the medium and variation in temperature 
Increasing the initial concentration of the glucose in the medium, did not result in further 
biomass production, suggesting the presence of a different limiting substrate.  A change in 
culture temperature from 28 °C to either 20, 30, 37 or 45°C did not substantially affect overall 
production of antimicrobials.  The level of each bioactive metabolite was affected differently 
at each temperature, resulting in different ratios of bioactive metabolites. Increasing the initial 
concentration of the glucose in the medium resulted in negligible amounts of antimicrobials 
being produced. 
 
6.2 Recommendations for further work 
The work performed in this study has provided information for the growth of SPRT and its 
production of antimicrobial molecules. This was achieved by gaining an understanding of the 
growth patterns of SPRT at laboratory scale (shake flasks and stirred tank bioreactors). From 
the findings, the following recommendations were made: 
 
 Studies into the selection and use of different bioreactors for growth of SPRT should be 
undertaken to overcome issues of foaming experienced with the STR.  Bubble columns 
and solid state technologies such as a fluidised bed and membrane bioreactors should 
be investigated. Alternatively, a STR with customised dimensions, impellor type 
(number and position) could manipulate fluid dynamics to provide sufficient mass 
transfer and culture homogeneity, whilst providing a low shear environment. 
 
 Analysis of the critical factor impeding antimicrobial production and design of a 
process decoupling biomass and antimicrobial production phases to circumvent it 
should be done. 
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 Extensive media studies should be performed to find suitable alternatives to the current 
laboratory medium (Hacène’s) that would favour antimicrobial production whilst 
keeping costs low.   
 
 Identification of the antimicrobial compounds and determination of their production 
triggers will aid research to improve product formation. 
 
 A better understanding of the metabolic pathways for antimicrobial agents and their 
induction trigger(s) is needed to enable more directed research to improve product 
formation. It will also allow monitoring of the effect of selective pressure(s) on 
responsible genes to keep the strain virile.  
 
 Antimicrobial activity and chemical entity tests should be used jointly in such studies, 
with ongoing assessment of antimicrobial activity spectrum of each compound.  
 
 Bioprospecting for novel compounds in niche environments should continue and 
contemporary techniques (e.g metagenomics) should be used to exploit the vast 
potential of antimicrobial compounds that nature has to offer.  
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B – Standard curve HPLC glucose measurements. 
 
Biorad Aminex® HPX-87H organic acid column (7.8 mm x 300 mm, Biorad, Cape Town, 
RSA) was used for the quantification of glucose and organic acids. Isocratic analyses was 
performed using 0.01M H2SO4, as the mobile phase, and an external column oven set to 40 °C. 
Injection volume used was 10 µl. The flow rate used was 0.5 mL/min. 
Glu 
(g/L)  
peak 
retention 
time  (min) 
peak area 
 0 9.382 546 
0 9.381 611 
0.1 9.39 172353 
0.1 9.388 211618 
0.2 9.386 451316 
0.2 9.385 492090 
0.5 9.383 1048289 
0.5 9.382 943361 
1 9.385 1984191 
1 9.383 1965752 
2 9.387 4122677 
2 9.385 4189369 
4 9.392 10103255 
4 9.39 8063567 
5 9.387 10062652 
5 9.392 10225337 
6 9.387 16021532 
6 9.39 11945317 
8 9.382 15935128 
8 9.39 11957819 
10 9.388 19965048 
  
 
 
 
 
 
y = 2E+06x
R² = 0.9542
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Figure B1 Example standard curve used for glucose measurements. (Fresh 
standards run alongside each experiment).    
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E - Raw data for batch Stirred tank reactor runs Chapter 5  
Time profile of batch cultivations of SPRT grown in a 7 L New Brunswick stir tank bioreactor 
(3 L working volume) containing Hacène’s medium, incubated at 28 °C. The biomass, DO, 
residual glucose and pH profiles are shown.   
NB. Agitation, DO, pH and Temperature were continuously measured online, only a selection of data is shown.  
 
Experiment A 
Time         
(h) 
CDW   
(g/L) 
lnCDW   
(g/L) 
Glu         
(g/L) 
Agitation 
(rpm)   
Time         
(h) 
DO            
(%) pH 
Temp     
(°C) 
0.0 0.33 -1.09 4.82 400   0 99.61 6.95 28 
2.0 0.54 -0.62 4.94 400   2 96.82 7.41 28 
4.0 0.76 -0.27 6.14 400   4 91.23 7.37 28 
6.0 1.37 0.31 5.61 400   6 80.40 7.36 28 
8.0 2.03 0.71 4.90 400   8 61.61 7.08 28 
10.0 4.27 1.45 3.64 400   10 49.56 6.32 28 
12.5 5.55 1.71 2.51 400   12 79.50 5.73 28 
14.5 6.04 1.80 1.22 400   14 89.56 5.40 28 
18.0 6.24 1.83 0.80 400   16 82.95 5.25 28 
18.5 5.69 1.74 0.54 400   18 84.11 5.28 28 
21.0 5.58 1.72 0.53 400   20 108.41 6.36 28 
24.0 4.28 1.45 0.50 400   22 78.76 6.94 28 
26.0 4.52 1.51 0.42 400   24 79.60 7.36 28 
 
Experiment  B   Experiment  B' 
Time         
(h) 
CDW   
(g/L) 
lnCDW   
(g/L) 
Glu         
(g/L)   
CDW   
(g/L) 
lnCDW   
(g/L) 
Glu         
(g/L) 
0 0.355 -1.037 5.143   0.371 -0.990 5.369 
2 0.317 -1.149 4.855   0.393 -0.934 5.389 
4 0.395 -0.929 4.149   0.787 -0.239 4.686 
6 0.500 -0.693 4.298   0.366 -1.006 4.881 
8 1.253 0.225 3.609   1.180 0.166 4.276 
11 2.250 0.811 3.283   2.024 0.705 4.067 
12 2.590 0.952 3.253   - - 3.278 
14.5 3.252 1.179 2.529   3.330 1.203 3.122 
16 2.314 0.839 1.009   2.985 1.094 2.619 
18.25 3.333 1.204 1.612   3.520 1.258 2.101 
22 2.453 0.897 0.885   2.400 0.875 1.600 
24 1.931 0.658 1.118   1.645 0.498 1.143 
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Experiment  C   Experiment  C' 
Time         
(h) 
CDW   
(g/L) 
lnCDW   
(g/L) 
Glu         
(g/L)   
Time         
(h) 
CDW   
(g/L) 
lnCDW   
(g/L) 
Glu         
(g/L) 
0.0 0.25 -1.37 5.52   0.00 0.25 -1.37 5.52 
3.0 0.54 -0.62 4.93   3.00 0.72 -0.33 4.18 
6.0 1.41 0.35 5.21   6.00 1.73 0.55 4.22 
9.0 2.94 1.08 2.80   9.00 2.92 1.07 2.82 
12.5 3.71 1.31 1.32   13.00 2.95 1.08 0.90 
16.0 2.73 1.00 0.75   16.00 3.29 1.19 0.61 
18.5 3.71 1.31 0.68   19.00 - - 0.62 
 
Experiment  B   Experiment  B' 
Time         
(h) 
Agitation 
(rpm) 
DO            
(%) pH 
Temp     
(°C)   
Agitation 
(rpm) 
DO            
(%) pH 
Temp     
(°C) 
0.0 250.12 99.69 6.99 28.05   249.70 99.29 7.04 28.01 
2.0 250.23 79.30 6.67 28.00   250.06 60.88 6.65 28.00 
4.0 249.62 62.53 6.63 28.00   249.68 41.57 6.57 28.00 
6.0 250.13 48.47 6.65 28.00   299.67 37.11 6.61 28.00 
8.0 400.12 73.27 6.73 28.01   400.05 70.07 6.63 28.00 
10.0 399.89 74.16 6.52 28.00   400.03 61.55 6.33 28.00 
12.0 399.45 93.39 5.73 28.01   399.94 81.80 5.52 28.01 
14.0 400.07 90.19 5.40 28.00   399.58 72.52 5.12 28.00 
16.0 249.97 63.96 5.44 27.99   249.95 70.07 5.13 27.99 
18.0 499.99 107.64 5.57 28.00   500.06 98.13 5.28 28.00 
20.0 500.53 132.40 5.65 27.99   500.76 101.51 5.39 28.00 
22.0 250.11 92.97 5.79 27.99   250.05 139.47 5.47 27.98 
24.0 200.48 89.92 5.97 28.00   198.80 64.14 5.60 28.00 
26.0 200.20 93.05 6.17 28.00   199.59 70.52 5.78 28.00 
32.5 199.94 93.74 6.86 27.99   199.46 93.84 6.49 27.99 
72.5 199.75 116.57 8.03 28.00   199.89 117.84 7.56 28.00 
92.0 200.70 117.53 7.95 28.00   200.28 118.82 7.51 28.00 
116.5 200.09 116.87 7.85 28.00   200.11 119.44 7.45 28.00 
121.0 200.38 117.30 7.83 28.00   199.56 118.59 7.43 28.00 
144.0 199.82 116.87 7.74 28.00   200.49 119.53 7.37 28.00 
168.0 200.41 117.53 7.74 28.00   200.56 120.60 7.31 27.99 
192.0 200.11 117.53 7.85 28.00   199.93 121.18 7.23 27.99 
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Experiment  C   Experiment  C' 
Time         
(h) 
Agitation 
(rpm) 
DO            
(%) pH 
Temp     
(°C)   
Agitation 
(rpm) 
DO            
(%) pH 
Temp     
(°C) 
0 200.49 100.10 7.14 27.82   199.37 99.83 6.92 27.85 
2 301.67 51.71 7.14 27.99   299.96 51.11 7.08 27.98 
3 300.21 24.98 7.11 28.00   300.04 18.44 7.14 28.06 
4 450.48 43.48 7.26 28.01   402.06 45.33 7.14 28.00 
6 546.91 39.42 7.38 28.00   498.95 53.39 7.40 27.95 
8 600.36 34.50 7.04 28.00   500.15 40.65 6.90 27.92 
9 699.89 39.17 6.78 28.01   549.99 50.86 6.71 27.98 
9.5 720.25 38.28 6.55 28.02   549.75 56.78 6.44 28.03 
10 749.82 41.66 6.31 28.00   600.04 69.81 6.39 27.91 
12 750.16 48.36 5.73 28.00   599.89 77.83 5.94 27.99 
12.5 749.71 50.07 5.57 28.00   600.17 80.06 5.81 27.99 
13 749.90 49.61 5.51 27.99   599.62 82.85 5.97 28.08 
14 650.12 43.94 5.42 27.99   650.28 94.51 6.07 28.02 
14.5 650.37 44.58 5.41 28.00   649.71 96.36 6.13 28.02 
15 649.79 51.46 5.43 28.01   650.24 98.33 6.21 27.99 
16 650.05 54.81 5.50 28.01   649.91 103.73 6.38 28.00 
18 199.98 52.39 5.64 27.99   199.66 117.83 7.13 27.99 
18.5 0.00 5.17 5.90 26.16   0.00 -0.56 7.21 27.90 
A
pp
en
di
x Pa
ge
 |
 9
6
 
Ex
pe
rim
en
t  
D
 
Ex
pe
rim
en
t  
D
' 
Ti
m
e 
  
(h
) 
C
D
W
 
(g
/L
) 
ln
C
D
W
 
(g
/L
) 
G
lu
   
   
 
(g
/L
) 
Ti
m
e 
  
(h
) 
A
gi
ta
tio
n 
(r
pm
) 
D
O
   
   
(%
) 
pH
 
Te
m
p 
   
 (°
C
) 
Ti
m
e 
  
(h
) 
C
D
W
 
(g
/L
) 
G
lu
   
   
 
(g
/L
) 
A
gi
ta
tio
n 
(r
pm
) 
D
O
   
   
(%
) 
pH
 
Te
m
p 
(°
C
) 
0.
0 
0.
35
 
-1
.0
4
5.
62
 
0.
0 
20
0.
00
 
92
.5
3 
6.
81
 
28
.0
5 
0 
0.
33
 
6.
88
 
60
0.
15
 
78
.3
5 
7.
14
 
24
.3
4 
3.
0 
0.
32
 
-1
.1
5
5.
14
 
3.
0 
29
9.
36
 
61
.2
5 
7.
33
 
28
.0
0 
3 
0.
51
 
7.
62
 
24
9.
94
 
42
.9
2 
7.
06
 
27
.9
1 
9.
5 
2.
94
 
1.
08
 
4.
73
 
6.
0 
35
0.
07
 
36
.4
4 
7.
29
 
28
.0
1 
6 
2.
4 
4.
74
 
50
0.
83
 
66
.8
6 
7.
33
 
28
 
12
.5
 
3.
53
 
1.
26
 
2.
57
 
9.
0 
49
9.
46
 
47
.4
2 
7.
13
 
28
.0
0 
8 
2.
6 
4.
56
 
49
9.
91
 
49
.8
8 
7.
08
 
28
 
26
.0
 
- 
- 
0.
67
 
12
.0
 
50
0.
09
 
44
.5
7 
7.
04
 
28
.0
0 
9 
3.
41
 
2.
84
 
49
9.
88
 
46
.3
 
6.
9 
28
 
31
.5
 
1.
25
 
0.
23
 
- 
15
.0
 
49
9.
94
 
55
.5
9 
7.
58
 
27
.9
9 
13
 
3.
53
 
1.
34
 
60
0.
02
 
72
.0
6 
7.
03
 
28
 
19
2.
0 
1.
28
 
0.
25
 
- 
18
.0
 
64
9.
92
 
96
.9
4 
6.
83
 
28
.0
0 
15
 
3.
5 
2.
1 
60
0.
18
 
87
.5
3 
7.
19
 
27
.9
9 
21
.0
 
59
9.
55
 
10
8.
99
 
7.
27
 
27
.9
9 
18
.5
 
- 
1.
04
 
60
0.
71
 
95
.1
1 
7.
38
 
28
 
24
.0
 
59
9.
87
 
11
8.
07
 
7.
35
 
28
.0
0 
19
.5
 
- 
0.
98
 
60
0.
35
 
97
.2
3 
7.
47
 
28
 
32
.5
 
49
9.
83
 
11
9.
72
 
7.
23
 
28
.0
0 
26
 
2.
64
 
0.
93
 
55
0.
16
 
10
5.
61
 
7.
64
 
27
.9
9 
72
.5
 
49
9.
96
 
10
4.
12
 
7.
58
 
28
.0
0 
72
.5
 
- 
0.
98
 
59
9.
85
 
11
5.
55
 
8.
54
 
28
 
92
.0
 
50
0.
10
 
10
4.
00
 
6.
65
 
28
.0
0 
92
 
2.
47
 
0.
99
 
59
9.
86
 
11
3.
24
 
8.
56
 
28
 
11
6.
5 
49
9.
98
 
11
2.
50
 
6.
54
 
28
.0
0 
11
6.
5 
1.
74
 
1.
02
 
30
0.
11
 
10
7.
62
 
8.
76
 
28
 
12
1.
0 
50
0.
32
 
11
3.
66
 
6.
52
 
28
.0
0 
12
1 
1.
22
 
0.
98
 
30
0.
22
 
10
9 
8.
83
 
27
.9
9 
14
4.
0 
49
9.
97
 
11
1.
63
 
6.
58
 
28
.0
0 
16
8 
1.
23
 
1.
06
 
29
9.
86
 
11
0.
89
 
8.
85
 
28
 
16
8.
0 
50
0.
18
 
11
6.
30
 
6.
96
 
28
.0
1 
19
2 
0.
04
 
1.
01
 
29
9.
87
 
10
7.
54
 
8.
7 
28
 
19
2.
0 
49
9.
67
 
11
4.
98
 
6.
96
 
28
.0
1 
20
2 
1.
3 
1.
11
 
29
7.
83
 
10
8.
54
 
8.
63
 
28
 
24
2 
0.
97
 
0.
84
 
30
0.
31
 
10
6.
82
 
7.
35
 
28
 
                                                                                                                                    Appendix 
Page | 97  
 
F – Temperature study raw data Chapter 5  
Time profile of batch cultivations of SPRT grown in a 7 L New Brunswick stir tank bioreactor 
(3 L working volume) containing Hacène’s medium, prior to transfer to shake flasks at different 
temperatures. The summary data for biomass, DO, residual glucose and pH profiles are shown 
for reactor data.   
NB. Agitation, DO, pH and Temperature were continuously measured online, only a selection of data is shown.  
 
Reactor data: 
Time         
(h) 
CDW   
(g/L) 
lnCDW   
(g/L) 
Glu         
(g/L) 
Agitation 
(rpm) 
DO            
(%) pH 
Temp     
(°C) 
0.0 0.37 -0.99 5.62 199.90 96.94 7.08 27.80 
2.0 - - - 299.68 25.77 6.91 27.99 
3.0 0.39 -0.93 4.48 299.85 50.41 6.97 28.00 
4.0 - - - 349.92 43.66 6.97 28.00 
6.0 - - - 399.96 35.98 6.99 28.03 
8.0 - - - 550.04 58.81 6.37 28.03 
9.0 - - - 550.54 52.33 5.93 28.05 
9.5 2.77 1.02 3.24 550.62 52.67 5.64 28.01 
10.0 - - - 550.04 53.52 5.38 28.02 
12.0 - - - 549.96 53.93 4.93 28.01 
12.5 - - - 550.01 55.76 4.93 28.00 
13.0 3.67 1.30 1.45 550.26 57.18 4.95 27.97 
15.0 3.97 1.38 - 549.84 61.11 5.10 28.00 
 
Shake Flask Data following transfer from STR, (n=2): 
  CDW (g/L) 
Time         
(d) 
20 °C 30 °C 37 °C 45 °C 
    SEM   SEM   SEM   SEM 
0 3.97 0.087 3.97 0.087 3.97 0.087 3.97 0.087 
3 3.74 0.300 5.37 0.001 5.23 0.003 3.86 0.000 
6 3.93 0.070 3.91 0.000 3.54 0.002 3.51 0.001 
10 2.68 0.000 3.77 0.002 3.22 0.001 2.97 0.000 
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